SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Organovo Holdings, Inc. – ‘10-Q’ for 9/30/22 – ‘JSON’

On:  Thursday, 11/10/22, at 4:07pm ET   ·   For:  9/30/22   ·   Accession #:  1564590-22-37381   ·   File #:  1-35996

Previous ‘10-Q’:  ‘10-Q’ on 8/11/22 for 6/30/22   ·   Next:  ‘10-Q’ on 2/9/23 for 12/31/22   ·   Latest:  ‘10-Q’ on 2/8/24 for 12/31/23   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/10/22  Organovo Holdings, Inc.           10-Q        9/30/22   51:5.6M                                   ActiveDisclosure/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.90M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     20K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     20K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     20K 
10: R1          Document and Entity Information                     HTML     70K 
11: R2          Condensed Consolidated Balance Sheets               HTML    101K 
12: R3          Condensed Consolidated Balance Sheets               HTML     27K 
                (Parenthetical)                                                  
13: R4          Unaudited Condensed Consolidated Statements of      HTML     86K 
                Operations and Other Comprehensive Loss                          
14: R5          Unaudited Condensed Consolidated Statements of      HTML     66K 
                Stockholders' Equity                                             
15: R6          Unaudited Condensed Consolidated Statements of      HTML     93K 
                Cash Flows                                                       
16: R7          Description of Business                             HTML     26K 
17: R8          Summary of Significant Accounting Policies          HTML     50K 
18: R9          Investments                                         HTML     20K 
19: R10         Stockholders' Equity                                HTML    218K 
20: R11         Collaborative Research, Development, and License    HTML     30K 
                Agreements                                                       
21: R12         Commitments and Contingencies                       HTML     22K 
22: R13         Leases                                              HTML     70K 
23: R14         Concentrations                                      HTML     20K 
24: R15         Related Parties                                     HTML     26K 
25: R16         Summary of Significant Accounting Policies          HTML     68K 
                (Policies)                                                       
26: R17         Summary of Significant Accounting Policies          HTML     30K 
                (Tables)                                                         
27: R18         Stockholders' Equity (Tables)                       HTML    216K 
28: R19         Leases (Tables)                                     HTML     66K 
29: R20         Summary of Significant Accounting Policies -        HTML     42K 
                Additional Information (Detail)                                  
30: R21         Summary of Significant Accounting Policies -        HTML     30K 
                Schedule of Activity for Investments in Equity                   
                Securities Measured at Fair Value (Detail)                       
31: R22         Investments - Additional Information (Detail)       HTML     37K 
32: R23         Stockholders' Equity - Schedule of Stock-based      HTML     24K 
                Compensation Expense (Detail)                                    
33: R24         Stockholders' Equity - Stock-based Compensation     HTML     36K 
                Expense and Valuation Information - Additional                   
                Information (Detail)                                             
34: R25         Stockholders' Equity - Fair Value of Employee       HTML     29K 
                Stock Options (Detail)                                           
35: R26         Stockholders' Equity - Fair Value of ESPP Shares    HTML     35K 
                (Detail)                                                         
36: R27         Stockholders' Equity - Preferred Stock -            HTML     20K 
                Additional Information (Detail)                                  
37: R28         Stockholders' Equity - Common Stock - Additional    HTML     45K 
                Information (Detail)                                             
38: R29         Stockholders' Equity - Summary of Company's RSUs    HTML     39K 
                Activity and Performance-Based RSUs Activity                     
                (Detail)                                                         
39: R30         Stockholders' Equity - Stock Options and Employee   HTML     62K 
                Stock Purchase Plan - Additional Information                     
                (Detail)                                                         
40: R31         Stockholders' Equity - Summary of Stock Option      HTML     49K 
                Activity (Detail)                                                
41: R32         Stockholders' Equity - Common Stock Reserved for    HTML     33K 
                Future Issuance (Detail)                                         
42: R33         Collaborative Research, Development, and License    HTML     70K 
                Agreements - Additional Information (Detail)                     
43: R34         Leases - Additional Information (Details)           HTML     49K 
44: R35         Leases - Schedule of Lease Liabilities and          HTML     34K 
                Corresponding Right-of-use Assets (Details)                      
45: R36         Leases - Schedule of Future Lease Payments          HTML     38K 
                (Details)                                                        
46: R37         Related Parties - Additional Information (Detail)   HTML     21K 
49: XML         IDEA XML File -- Filing Summary                      XML     89K 
47: XML         XBRL Instance -- onvo-10q_20220930_htm               XML   1.14M 
48: EXCEL       IDEA Workbook of Financial Reports                  XLSX     91K 
 6: EX-101.CAL  XBRL Calculations -- onvo-20220930_cal               XML     97K 
 7: EX-101.DEF  XBRL Definitions -- onvo-20220930_def                XML    303K 
 8: EX-101.LAB  XBRL Labels -- onvo-20220930_lab                     XML    796K 
 9: EX-101.PRE  XBRL Presentations -- onvo-20220930_pre              XML    583K 
 5: EX-101.SCH  XBRL Schema -- onvo-20220930                         XSD    117K 
50: JSON        XBRL Instance as JSON Data -- MetaLinks              247±   391K 
51: ZIP         XBRL Zipped Folder -- 0001564590-22-037381-xbrl      Zip    222K 


‘JSON’   —   XBRL Instance as JSON Data — MetaLinks


This File is an XBRL Instance as JavaScript Object Notation (JSON) Data.



{
"instance":  {
    "onvo-10q_20220930.htm":  {
        "axisCustom":  0,
        "axisStandard":  15,
        "contextCount":  126,
        "dts":  {
            "calculationLink":  {
                "local":  [
                    "onvo-20220930_cal.xml"
                    ]
                },
            "definitionLink":  {
                "local":  [
                    "onvo-20220930_def.xml"
                    ]
                },
            "inline":  {
                "local":  [
                    "onvo-10q_20220930.htm"
                    ]
                },
            "labelLink":  {
                "local":  [
                    "onvo-20220930_lab.xml"
                    ]
                },
            "presentationLink":  {
                "local":  [
                    "onvo-20220930_pre.xml"
                    ]
                },
            "schema":  {
                "local":  [
                    "onvo-20220930.xsd"
                    ],
                "remote":  [
                    "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
                    "http://www.xbrl.org/2005/xbrldt-2005.xsd",
                    "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
                    "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
                    "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
                    "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
                    "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
                    "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
                    "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
                    "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
                    "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
                    "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
                    "https://xbrl.sec.gov/country/2022/country-2022.xsd",
                    "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
                    "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
                    "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
                    "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
                    "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
                    "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
                    ]
                }
            },
        "elementCount":  332,
        "entityCount":  1,
        "hidden":  {
            "http://fasb.org/us-gaap/2022":  13,
            "http://www.organovo.com/20220930":  1,
            "http://xbrl.sec.gov/dei/2022":  6,
            "total":  20
            },
        "keyCustom":  37,
        "keyStandard":  182,
        "memberCustom":  20,
        "memberStandard":  12,
        "nsprefix":  "onvo",
        "nsuri":  "http://www.organovo.com/20220930",
        "report":  {
            "R1":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "dei:DocumentType",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "document",
                "isDefault":  "true",
                "longName":  "100000 - Document - Document and Entity Information",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation",
                "shortName":  "Document and Entity Information",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "dei:DocumentType",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R10":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100090 - Disclosure - Stockholders' Equity",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquity",
                "shortName":  "Stockholders' Equity",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R11":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CollaborativeArrangementDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100100 - Disclosure - Collaborative Research, Development, and License Agreements",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreements",
                "shortName":  "Collaborative Research, Development, and License Agreements",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CollaborativeArrangementDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R12":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommitmentsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100110 - Disclosure - Commitments and Contingencies",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingencies",
                "shortName":  "Commitments and Contingencies",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommitmentsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R13":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LesseeOperatingLeasesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100120 - Disclosure - Leases",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeases",
                "shortName":  "Leases",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LesseeOperatingLeasesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R14":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ConcentrationRiskDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100130 - Disclosure - Concentrations",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureConcentrations",
                "shortName":  "Concentrations",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ConcentrationRiskDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R15":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100140 - Disclosure - Related Parties",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureRelatedParties",
                "shortName":  "Related Parties",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R16":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "onvo:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100150 - Disclosure - Summary of Significant Accounting Policies (Policies)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
                "shortName":  "Summary of Significant Accounting Policies (Policies)",
                "subGroupType":  "policies",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "onvo:BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R17":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "onvo:ScheduleOfInvestmentsInEquitySecuritiesMeasuredAtFairValueTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100160 - Disclosure - Summary of Significant Accounting Policies (Tables)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables",
                "shortName":  "Summary of Significant Accounting Policies (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "onvo:ScheduleOfInvestmentsInEquitySecuritiesMeasuredAtFairValueTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R18":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100170 - Disclosure - Stockholders' Equity (Tables)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityTables",
                "shortName":  "Stockholders' Equity (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R19":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LeaseCostTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100180 - Disclosure - Leases (Tables)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesTables",
                "shortName":  "Leases (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LeaseCostTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R2":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "100010 - Statement - Condensed Consolidated Balance Sheets",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets",
                "shortName":  "Condensed Consolidated Balance Sheets",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220930",
                    "decimals":  "-3",
                    "lang":  null,
                    "name":  "onvo:EquitySecuritiesCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    }
                },
            "R20":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100190 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
                "shortName":  "Summary of Significant Accounting Policies - Additional Information (Detail)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "us-gaap:EarningsPerSharePolicyTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220701_20220930",
                    "decimals":  "INF",
                    "lang":  null,
                    "name":  "us-gaap:DilutiveSecurities",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    }
                },
            "R21":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:PaymentsToAcquireEquitySecuritiesFvNi",
                    "reportCount":  1,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100200 - Disclosure - Summary of Significant Accounting Policies - Schedule of Activity for Investments in Equity Securities Measured at Fair Value (Detail)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfActivityForInvestmentsInEquitySecuritiesMeasuredAtFairValueDetail",
                "shortName":  "Summary of Significant Accounting Policies - Schedule of Activity for Investments in Equity Securities Measured at Fair Value (Detail)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "onvo:ScheduleOfInvestmentsInEquitySecuritiesMeasuredAtFairValueTableTextBlock",
                        "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_20220331",
                    "decimals":  "-3",
                    "lang":  null,
                    "name":  "us-gaap:EquitySecuritiesFVNINoncurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    }
                },
            "R22":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "us-gaap:InvestmentTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220701_20220930",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DebtSecuritiesUnrealizedGainLoss",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100210 - Disclosure - Investments - Additional Information (Detail)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
                "shortName":  "Investments - Additional Information (Detail)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "us-gaap:InvestmentTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220701_20220930",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DebtSecuritiesUnrealizedGainLoss",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    }
                },
            "R23":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220701_20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:AllocatedShareBasedCompensationExpense",
                    "reportCount":  1,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100220 - Disclosure - Stockholders' Equity - Schedule of Stock-based Compensation Expense (Detail)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockBasedCompensationExpenseDetail",
                "shortName":  "Stockholders' Equity - Schedule of Stock-based Compensation Expense (Detail)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20220701_20220930",
                    "decimals":  "-3",
                    "lang":  null,
                    "name":  "us-gaap:AllocatedShareBasedCompensationExpense",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    }
                },
            "R24":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220930",
                    "decimals":  "-5",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
                    "reportCount":  1,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100230 - Disclosure - Stockholders' Equity - Stock-based Compensation Expense and Valuation Information - Additional Information (Detail)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockBasedCompensationExpenseAndValuationInformationAdditionalInformationDetail",
                "shortName":  "Stockholders' Equity - Stock-based Compensation Expense and Valuation Information - Additional Information (Detail)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20220401_20220930",
                    "decimals":  null,
                    "lang":  "en-US",
                    "name":  "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R25":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220701_20220930",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
                    "reportCount":  1,
                    "unitRef":  "U_xbrlipure",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100240 - Disclosure - Stockholders' Equity - Fair Value of Employee Stock Options (Detail)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityFairValueOfEmployeeStockOptionsDetail",
                "shortName":  "Stockholders' Equity - Fair Value of Employee Stock Options (Detail)",
                "subGroupType":  "details",
                "uniqueAnchor":  null
                },
            "R26":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220701_20220930",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
                    "reportCount":  1,
                    "unitRef":  "U_xbrlipure",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100250 - Disclosure - Stockholders' Equity - Fair Value of ESPP Shares (Detail)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityFairValueOfESPPSharesDetail",
                "shortName":  "Stockholders' Equity - Fair Value of ESPP Shares (Detail)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_onvoESPPSharesMember_20220701_20220930",
                    "decimals":  "INF",
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_xbrlipure",
                    "xsiNil":  "false"
                    }
                },
            "R27":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220930",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:PreferredStockSharesAuthorized",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_xbrlishares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100260 - Disclosure - Stockholders' Equity - Preferred Stock - Additional Information (Detail)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityPreferredStockAdditionalInformationDetail",
                "shortName":  "Stockholders' Equity - Preferred Stock - Additional Information (Detail)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220930",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:PreferredStockSharesAuthorized",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_xbrlishares",
                    "xsiNil":  "false"
                    }
                },
            "R28":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20210119",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "onvo:CombinationOfSecuritiesAuthorizedForOfferAndSale",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100270 - Disclosure - Stockholders' Equity - Common Stock - Additional Information (Detail)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
                "shortName":  "Stockholders' Equity - Common Stock - Additional Information (Detail)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20210119",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "onvo:CombinationOfSecuritiesAuthorizedForOfferAndSale",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    }
                },
            "R29":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20220331",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_xbrlishares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100280 - Disclosure - Stockholders' Equity - Summary of Company's RSUs Activity and Performance-Based RSUs Activity (Detail)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanySRsusActivityAndPerformanceBasedRsusActivityDetail",
                "shortName":  "Stockholders' Equity - Summary of Company's RSUs Activity and Performance-Based RSUs Activity (Detail)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "ix:continuation",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20220331",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_xbrlishares",
                    "xsiNil":  "false"
                    }
                },
            "R3":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220930",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CommonStockParOrStatedValuePerShare",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_iso4217USD_xbrlishares",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
                "shortName":  "Condensed Consolidated Balance Sheets (Parenthetical)",
                "subGroupType":  "parenthetical",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220930",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CommonStockParOrStatedValuePerShare",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_iso4217USD_xbrlishares",
                    "xsiNil":  "false"
                    }
                },
            "R30":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  "2",
                    "first":  true,
                    "lang":  null,
                    "name":  "onvo:VestingCriteriaProbabilityOfAchievementPercentage",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_xbrlipure",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100290 - Disclosure - Stockholders' Equity - Stock Options and Employee Stock Purchase Plan - Additional Information (Detail)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail",
                "shortName":  "Stockholders' Equity - Stock Options and Employee Stock Purchase Plan - Additional Information (Detail)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  "2",
                    "first":  true,
                    "lang":  null,
                    "name":  "onvo:VestingCriteriaProbabilityOfAchievementPercentage",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_xbrlipure",
                    "xsiNil":  "false"
                    }
                },
            "R31":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220331",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_xbrlishares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100300 - Disclosure - Stockholders' Equity - Summary of Stock Option Activity (Detail)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetail",
                "shortName":  "Stockholders' Equity - Summary of Stock Option Activity (Detail)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220331",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_xbrlishares",
                    "xsiNil":  "false"
                    }
                },
            "R32":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "onvo:CommonStockCapitalSharesReservedForFutureIssuanceTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220930",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
                    "reportCount":  1,
                    "unitRef":  "U_xbrlishares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100310 - Disclosure - Stockholders' Equity - Common Stock Reserved for Future Issuance (Detail)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetail",
                "shortName":  "Stockholders' Equity - Common Stock Reserved for Future Issuance (Detail)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "onvo:CommonStockCapitalSharesReservedForFutureIssuanceTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_us-gaapPlanNameAxis_onvoEquityIncentivePlanTwoThousandTwelveMember_20220930",
                    "decimals":  "INF",
                    "lang":  null,
                    "name":  "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_xbrlishares",
                    "xsiNil":  "false"
                    }
                },
            "R33":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220701_20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
                    "reportCount":  1,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100320 - Disclosure - Collaborative Research, Development, and License Agreements - Additional Information (Detail)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail",
                "shortName":  "Collaborative Research, Development, and License Agreements - Additional Information (Detail)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "us-gaap:CollaborativeArrangementDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_onvoBICOGroupABMember_20220222_20220222",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "onvo:NonrefundableUpfrontFeePaid",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    }
                },
            "R34":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20191001_20210731",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "onvo:MonthlyRentPayments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100330 - Disclosure - Leases - Additional Information (Details)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
                "shortName":  "Leases - Additional Information (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20191001_20210731",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "onvo:MonthlyRentPayments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    }
                },
            "R35":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:LeaseCostTableTextBlock",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "onvo:OperatingLeaseRightOfUseAssetNonCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100340 - Disclosure - Leases - Schedule of Lease Liabilities and Corresponding Right-of-use Assets (Details)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails",
                "shortName":  "Leases - Schedule of Lease Liabilities and Corresponding Right-of-use Assets (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:LeaseCostTableTextBlock",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "onvo:OperatingLeaseRightOfUseAssetNonCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    }
                },
            "R36":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100350 - Disclosure - Leases - Schedule of Future Lease Payments (Details)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsDetails",
                "shortName":  "Leases - Schedule of Future Lease Payments (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    }
                },
            "R37":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "p",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_onvoViscientBiosciencesMember_20220701_20220930",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "onvo:ConsultingExpenses",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100370 - Disclosure - Related Parties - Additional Information (Detail)",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetail",
                "shortName":  "Related Parties - Additional Information (Detail)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "p",
                        "ix:continuation",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_onvoViscientBiosciencesMember_20220701_20220930",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "onvo:ConsultingExpenses",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    }
                },
            "R4":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220701_20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
                    "reportCount":  1,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "100030 - Statement - Unaudited Condensed Consolidated Statements of Operations and Other Comprehensive Loss",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss",
                "shortName":  "Unaudited Condensed Consolidated Statements of Operations and Other Comprehensive Loss",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220701_20220930",
                    "decimals":  "-3",
                    "lang":  null,
                    "name":  "us-gaap:ResearchAndDevelopmentExpense",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    }
                },
            "R5":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20210331",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                    "reportCount":  1,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "100040 - Statement - Unaudited Condensed Consolidated Statements of Stockholders' Equity",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfStockholdersEquity",
                "shortName":  "Unaudited Condensed Consolidated Statements of Stockholders' Equity",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20210401_20210630",
                    "decimals":  "-3",
                    "lang":  null,
                    "name":  "onvo:StockIssuedDuringPeriodValuePublicOffering",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    }
                },
            "R6":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220701_20220930",
                    "decimals":  "-3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ProfitLoss",
                    "reportCount":  1,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "100050 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows",
                "shortName":  "Unaudited Condensed Consolidated Statements of Cash Flows",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  "-3",
                    "lang":  null,
                    "name":  "onvo:AccretionOnShortTermInvestments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "U_iso4217USD",
                    "xsiNil":  "false"
                    }
                },
            "R7":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:NatureOfOperations",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100060 - Disclosure - Description of Business",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureDescriptionOfBusiness",
                "shortName":  "Description of Business",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:NatureOfOperations",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R8":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100070 - Disclosure - Summary of Significant Accounting Policies",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies",
                "shortName":  "Summary of Significant Accounting Policies",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R9":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:InvestmentTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "100080 - Disclosure - Investments",
                "role":  "http://www.organovo.com/20220930/taxonomy/role/DisclosureInvestments",
                "shortName":  "Investments",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "onvo-10q_20220930.htm",
                    "contextRef":  "C_0001497253_20220401_20220930",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:InvestmentTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                }
            },
        "segmentCount":  32,
        "tag":  {
            "dei_AmendmentFlag":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
                            "label":  "Amendment Flag",
                            "verboseLabel":  "Amendment Flag"
                            }
                        }
                    },
                "localname":  "AmendmentFlag",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_CityAreaCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Area code of city",
                            "label":  "City Area Code",
                            "terseLabel":  "City Area Code"
                            }
                        }
                    },
                "localname":  "CityAreaCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_CoverAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cover page.",
                            "label":  "Cover [Abstract]"
                            }
                        }
                    },
                "localname":  "CoverAbstract",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "xbrltype":  "stringItemType"
                },
            "dei_CurrentFiscalYearEndDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "End date of current fiscal year in the format --MM-DD.",
                            "label":  "Current Fiscal Year End Date",
                            "terseLabel":  "Current Fiscal Year End Date"
                            }
                        }
                    },
                "localname":  "CurrentFiscalYearEndDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "gMonthDayItemType"
                },
            "dei_DocumentFiscalPeriodFocus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
                            "label":  "Document Fiscal Period Focus",
                            "terseLabel":  "Document Fiscal Period Focus"
                            }
                        }
                    },
                "localname":  "DocumentFiscalPeriodFocus",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "fiscalPeriodItemType"
                },
            "dei_DocumentFiscalYearFocus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "This is focus fiscal year of the document report in YYYY format.  For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus.  Example: 2006.",
                            "label":  "Document Fiscal Year Focus",
                            "terseLabel":  "Document Fiscal Year Focus"
                            }
                        }
                    },
                "localname":  "DocumentFiscalYearFocus",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "gYearItemType"
                },
            "dei_DocumentPeriodEndDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
                            "label":  "Document Period End Date",
                            "verboseLabel":  "Document Period End Date"
                            }
                        }
                    },
                "localname":  "DocumentPeriodEndDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "dateItemType"
                },
            "dei_DocumentQuarterlyReport":  {
                "auth_ref":  [
                    "r400"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as an quarterly report.",
                            "label":  "Document Quarterly Report",
                            "terseLabel":  "Document Quarterly Report"
                            }
                        }
                    },
                "localname":  "DocumentQuarterlyReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentTransitionReport":  {
                "auth_ref":  [
                    "r401"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as a transition report.",
                            "label":  "Document Transition Report",
                            "terseLabel":  "Document Transition Report"
                            }
                        }
                    },
                "localname":  "DocumentTransitionReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentType":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc).  The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
                            "label":  "Document Type",
                            "terseLabel":  "Document Type"
                            }
                        }
                    },
                "localname":  "DocumentType",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "submissionTypeItemType"
                },
            "dei_EntityAddressAddressLine1":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Address Line 1 such as Attn, Building Name, Street Name",
                            "label":  "Entity Address Address Line1",
                            "terseLabel":  "Entity Address, Address Line One"
                            }
                        }
                    },
                "localname":  "EntityAddressAddressLine1",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressAddressLine2":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Address Line 2 such as Street or Suite number",
                            "label":  "Entity Address Address Line2",
                            "verboseLabel":  "Entity Address, Address Line Two"
                            }
                        }
                    },
                "localname":  "EntityAddressAddressLine2",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressCityOrTown":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the City or Town",
                            "label":  "Entity Address City Or Town",
                            "terseLabel":  "Entity Address, City or Town"
                            }
                        }
                    },
                "localname":  "EntityAddressCityOrTown",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressPostalZipCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Code for the postal or zip code",
                            "label":  "Entity Address Postal Zip Code",
                            "terseLabel":  "Entity Address, Postal Zip Code"
                            }
                        }
                    },
                "localname":  "EntityAddressPostalZipCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressStateOrProvince":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the state or province.",
                            "label":  "Entity Address State Or Province",
                            "terseLabel":  "Entity Address, State or Province"
                            }
                        }
                    },
                "localname":  "EntityAddressStateOrProvince",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "stateOrProvinceItemType"
                },
            "dei_EntityCentralIndexKey":  {
                "auth_ref":  [
                    "r398"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC.  It is commonly abbreviated as CIK.",
                            "label":  "Entity Central Index Key",
                            "terseLabel":  "Entity Central Index Key"
                            }
                        }
                    },
                "localname":  "EntityCentralIndexKey",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "centralIndexKeyItemType"
                },
            "dei_EntityCommonStockSharesOutstanding":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report.  Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
                            "label":  "Entity Common Stock Shares Outstanding",
                            "terseLabel":  "Entity Common Stock, Shares Outstanding"
                            }
                        }
                    },
                "localname":  "EntityCommonStockSharesOutstanding",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "dei_EntityCurrentReportingStatus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.  This information should be based on the registrant's current or most recent filing containing the related disclosure.",
                            "label":  "Entity Current Reporting Status",
                            "terseLabel":  "Entity Current Reporting Status"
                            }
                        }
                    },
                "localname":  "EntityCurrentReportingStatus",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityEmergingGrowthCompany":  {
                "auth_ref":  [
                    "r398"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate if registrant meets the emerging growth company criteria.",
                            "label":  "Entity Emerging Growth Company",
                            "terseLabel":  "Entity Emerging Growth Company"
                            }
                        }
                    },
                "localname":  "EntityEmergingGrowthCompany",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityFileNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Commission file number.  The field allows up to 17 characters.  The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
                            "label":  "Entity File Number",
                            "terseLabel":  "Entity File Number"
                            }
                        }
                    },
                "localname":  "EntityFileNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "fileNumberItemType"
                },
            "dei_EntityFilerCategory":  {
                "auth_ref":  [
                    "r398"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate whether the registrant is one of the following:  Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer.  Definitions of these categories are stated in Rule 12b-2 of the Exchange Act.  This information should be based on the registrant's current or most recent filing containing the related disclosure.",
                            "label":  "Entity Filer Category",
                            "terseLabel":  "Entity Filer Category"
                            }
                        }
                    },
                "localname":  "EntityFilerCategory",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "filerCategoryItemType"
                },
            "dei_EntityIncorporationStateCountryCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Two-character EDGAR code representing the state or country of incorporation.",
                            "label":  "Entity Incorporation State Country Code",
                            "terseLabel":  "Entity Incorporation, State or Country Code"
                            }
                        }
                    },
                "localname":  "EntityIncorporationStateCountryCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "edgarStateCountryItemType"
                },
            "dei_EntityInteractiveDataCurrent":  {
                "auth_ref":  [
                    "r402"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
                            "label":  "Entity Interactive Data Current",
                            "terseLabel":  "Entity Interactive Data Current"
                            }
                        }
                    },
                "localname":  "EntityInteractiveDataCurrent",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityRegistrantName":  {
                "auth_ref":  [
                    "r398"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
                            "label":  "Entity Registrant Name",
                            "terseLabel":  "Entity Registrant Name"
                            }
                        }
                    },
                "localname":  "EntityRegistrantName",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityShellCompany":  {
                "auth_ref":  [
                    "r398"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
                            "label":  "Entity Shell Company",
                            "terseLabel":  "Entity Shell Company"
                            }
                        }
                    },
                "localname":  "EntityShellCompany",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntitySmallBusiness":  {
                "auth_ref":  [
                    "r398"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicates that the company is a Smaller Reporting Company (SRC).",
                            "label":  "Entity Small Business",
                            "terseLabel":  "Entity Small Business"
                            }
                        }
                    },
                "localname":  "EntitySmallBusiness",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityTaxIdentificationNumber":  {
                "auth_ref":  [
                    "r398"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
                            "label":  "Entity Tax Identification Number",
                            "terseLabel":  "Entity Tax Identification Number"
                            }
                        }
                    },
                "localname":  "EntityTaxIdentificationNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "employerIdItemType"
                },
            "dei_LocalPhoneNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Local phone number for entity.",
                            "label":  "Local Phone Number",
                            "terseLabel":  "Local Phone Number"
                            }
                        }
                    },
                "localname":  "LocalPhoneNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_Security12bTitle":  {
                "auth_ref":  [
                    "r397"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Title of a 12(b) registered security.",
                            "label":  "Security12b Title",
                            "terseLabel":  "Title of 12(b) Security"
                            }
                        }
                    },
                "localname":  "Security12bTitle",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "securityTitleItemType"
                },
            "dei_SecurityExchangeName":  {
                "auth_ref":  [
                    "r399"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the Exchange on which a security is registered.",
                            "label":  "Security Exchange Name",
                            "terseLabel":  "Security Exchange Name"
                            }
                        }
                    },
                "localname":  "SecurityExchangeName",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "edgarExchangeCodeItemType"
                },
            "dei_TradingSymbol":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Trading symbol of an instrument as listed on an exchange.",
                            "label":  "Trading Symbol",
                            "terseLabel":  "Trading Symbol"
                            }
                        }
                    },
                "localname":  "TradingSymbol",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation"
                    ],
                "xbrltype":  "tradingSymbolItemType"
                },
            "onvo_AccretionOnShortTermInvestments":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  10120.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accretion on short-term investments.",
                            "label":  "Accretion On Short Term Investments",
                            "negatedLabel":  "Accretion on short-term investments"
                            }
                        }
                    },
                "localname":  "AccretionOnShortTermInvestments",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "onvo_AtTheMarketFacilityMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "At-the-market facility.",
                            "label":  "At The Market Facility [Member]",
                            "terseLabel":  "At-The-Market Facility [Member]"
                            }
                        }
                    },
                "localname":  "AtTheMarketFacilityMember",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "onvo_BICOGroupABMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "BICO Group AB.",
                            "label":  "B I C O Group A B [Member]",
                            "terseLabel":  "BICO Group AB [Member]"
                            }
                        }
                    },
                "localname":  "BICOGroupABMember",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "onvo_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Basis of presentation and principles of consolidation.",
                            "label":  "Basis Of Presentation And Principles Of Consolidation Policy [Text Block]",
                            "terseLabel":  "Basis of Presentation and Principles of Consolidation"
                            }
                        }
                    },
                "localname":  "BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "onvo_ChiefScientificOfficerMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Chief scientific officer.",
                            "label":  "Chief Scientific Officer [Member]",
                            "terseLabel":  "Chief Scientific Officer [Member]"
                            }
                        }
                    },
                "localname":  "ChiefScientificOfficerMember",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "onvo_ClemsonUniversityMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Clemson University.",
                            "label":  "Clemson University [Member]",
                            "terseLabel":  "Clemson University [Member]"
                            }
                        }
                    },
                "localname":  "ClemsonUniversityMember",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "onvo_CombinationOfSecuritiesAuthorizedForOfferAndSale":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Combination of securities authorized for offer and sale.",
                            "label":  "Combination Of Securities Authorized For Offer And Sale",
                            "terseLabel":  "Securities authorized for offer and sale, amount"
                            }
                        }
                    },
                "localname":  "CombinationOfSecuritiesAuthorizedForOfferAndSale",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "onvo_CommonStockCapitalSharesReservedForFutureIssuanceTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Common stock capital shares reserved for future issuance.",
                            "label":  "Common Stock Capital Shares Reserved For Future Issuance Table [Text Block]",
                            "terseLabel":  "Common Stock Reserved for Future Issuance"
                            }
                        }
                    },
                "localname":  "CommonStockCapitalSharesReservedForFutureIssuanceTableTextBlock",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "onvo_CommonStockCapitalValueReservedForFutureIssuance":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Common stock capital value reserved for future issuance.",
                            "label":  "Common Stock Capital Value Reserved For Future Issuance",
                            "terseLabel":  "Common stock value reserved for future issuance"
                            }
                        }
                    },
                "localname":  "CommonStockCapitalValueReservedForFutureIssuance",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "onvo_ConsultingExpenses":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Consulting expenses.",
                            "label":  "Consulting Expenses",
                            "terseLabel":  "Consulting expenses"
                            }
                        }
                    },
                "localname":  "ConsultingExpenses",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "onvo_ESPPSharesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "ESPP shares.",
                            "label":  "E S P P Shares [Member]",
                            "terseLabel":  "ESPP Shares [Member]"
                            }
                        }
                    },
                "localname":  "ESPPSharesMember",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityFairValueOfESPPSharesDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityTables"
                    ],
                "xbrltype":  "domainItemType"
                },
            "onvo_EmployeeStockPurchasePlanMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Employee Stock Purchase Plan.",
                            "label":  "Employee Stock Purchase Plan [Member]",
                            "terseLabel":  "2016 Employee Stock Purchase Plan [Member]"
                            }
                        }
                    },
                "localname":  "EmployeeStockPurchasePlanMember",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockBasedCompensationExpenseAndValuationInformationAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "onvo_EquityIncentivePlanTwoThousandTwelveMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Equity incentive plan two thousand twelve.",
                            "label":  "Equity Incentive Plan Two Thousand Twelve [Member]",
                            "terseLabel":  "Equity Incentive Plan 2012 [Member]"
                            }
                        }
                    },
                "localname":  "EquityIncentivePlanTwoThousandTwelveMember",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "onvo_EquitySalesAgreementExpirationDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Equity sales agreement expiration date.",
                            "label":  "Equity Sales Agreement Expiration Date",
                            "terseLabel":  "Equity sales agreement expiration date"
                            }
                        }
                    },
                "localname":  "EquitySalesAgreementExpirationDate",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail"
                    ],
                "xbrltype":  "dateItemType"
                },
            "onvo_EquitySecuritiesCurrent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  10190.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Equity securities current.",
                            "label":  "Equity Securities Current",
                            "terseLabel":  "Investment in equity securities"
                            }
                        }
                    },
                "localname":  "EquitySecuritiesCurrent",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "onvo_ExcessOfMinimumAnnualRoyaltiesPayment":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Excess of minimum annual royalties payment.",
                            "label":  "Excess Of Minimum Annual Royalties Payment",
                            "terseLabel":  "Excess of minimum annual royalties payment"
                            }
                        }
                    },
                "localname":  "ExcessOfMinimumAnnualRoyaltiesPayment",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "onvo_ExecutiveChairmanMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Executive chairman.",
                            "label":  "Executive Chairman [Member]",
                            "terseLabel":  "Executive Chairman [Member]"
                            }
                        }
                    },
                "localname":  "ExecutiveChairmanMember",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "onvo_HistologyServicesToRelatedParties":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Histology services to related parties.",
                            "label":  "Histology Services To Related Parties",
                            "terseLabel":  "Histology services to related parties"
                            }
                        }
                    },
                "localname":  "HistologyServicesToRelatedParties",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "onvo_IncentiveAwardPlanMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Incentive award plan.",
                            "label":  "Incentive Award Plan [Member]",
                            "terseLabel":  "Incentive Award Plan [Member]"
                            }
                        }
                    },
                "localname":  "IncentiveAwardPlanMember",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "onvo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  10180.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Increase decrease in operating lease right-of-use assets and liabilities, net.",
                            "label":  "Increase Decrease In Operating Lease Right Of Use Assets And Liabilities Net",
                            "terseLabel":  "Operating lease right-of-use assets and liabilities, net"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "onvo_InterestIncomeOnShortTermInvestments":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of interest income on short-term investments",
                            "label":  "Interest Income On Short Term Investments",
                            "terseLabel":  "Interest income on short-term investments"
                            }
                        }
                    },
                "localname":  "InterestIncomeOnShortTermInvestments",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "onvo_InvestmentsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Investments.",
                            "label":  "Investments [Line Items]",
                            "terseLabel":  "Investments [Line Items]"
                            }
                        }
                    },
                "localname":  "InvestmentsLineItems",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "onvo_InvestmentsTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Investments.",
                            "label":  "Investments [Table]",
                            "terseLabel":  "Investments [Table]"
                            }
                        }
                    },
                "localname":  "InvestmentsTable",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "onvo_LabAndOfficeSpaceAreaUnderLeaseAgreement":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Lab and office space area under lease agreement.",
                            "label":  "Lab And Office Space Area Under Lease Agreement",
                            "terseLabel":  "Lab and Office space under lease agreement"
                            }
                        }
                    },
                "localname":  "LabAndOfficeSpaceAreaUnderLeaseAgreement",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "areaItemType"
                },
            "onvo_LicenseAgreementExpirationMonth":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "License agreement expiration month.",
                            "label":  "License Agreement Expiration Month",
                            "terseLabel":  "Expected expiration year of license agreement"
                            }
                        }
                    },
                "localname":  "LicenseAgreementExpirationMonth",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail"
                    ],
                "xbrltype":  "gYearMonthItemType"
                },
            "onvo_LicenseAgreementExpirationYearStart":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "License agreement expiration year start.",
                            "label":  "License Agreement Expiration Year Start",
                            "terseLabel":  "Expected expiration year of license agreement"
                            }
                        }
                    },
                "localname":  "LicenseAgreementExpirationYearStart",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail"
                    ],
                "xbrltype":  "gYearItemType"
                },
            "onvo_LiquidityPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Liquidity policy.",
                            "label":  "Liquidity Policy [Text Block]",
                            "terseLabel":  "Liquidity"
                            }
                        }
                    },
                "localname":  "LiquidityPolicyTextBlock",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "onvo_MinimumAnnualRoyaltyPayment":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Minimum annual royalty payment.",
                            "label":  "Minimum Annual Royalty Payment",
                            "terseLabel":  "Minimum annual royalty paid"
                            }
                        }
                    },
                "localname":  "MinimumAnnualRoyaltyPayment",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "onvo_MonthlyRentPayments":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Monthly rent payments.",
                            "label":  "Monthly Rent Payments",
                            "terseLabel":  "Monthly rental payments"
                            }
                        }
                    },
                "localname":  "MonthlyRentPayments",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "onvo_NonrefundableUpfrontFeePaid":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Nonrefundable upfront fee paid.",
                            "label":  "Nonrefundable Upfront Fee Paid",
                            "terseLabel":  "Nonrefundable upfront fee paid"
                            }
                        }
                    },
                "localname":  "NonrefundableUpfrontFeePaid",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "onvo_NumberOfLeaseAgreement":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of lease agreement.",
                            "label":  "Number Of Lease Agreement",
                            "terseLabel":  "Number of lease agreement"
                            }
                        }
                    },
                "localname":  "NumberOfLeaseAgreement",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "integerItemType"
                },
            "onvo_NumberOfParticipantsEnrolledInEmployeeStockPurchasePlan":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of participants enrolled in employee stock purchase plan.",
                            "label":  "Number Of Participants Enrolled In Employee Stock Purchase Plan",
                            "terseLabel":  "Participants enrolled into the employee stock purchase plan"
                            }
                        }
                    },
                "localname":  "NumberOfParticipantsEnrolledInEmployeeStockPurchasePlan",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockBasedCompensationExpenseAndValuationInformationAdditionalInformationDetail"
                    ],
                "xbrltype":  "integerItemType"
                },
            "onvo_OperatingLeaseLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Operating lease.",
                            "label":  "Operating Lease [Line Items]",
                            "terseLabel":  "Operating Lease [Line Items]"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLineItems",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "onvo_OperatingLeaseRightOfUseAssetNonCurrent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails":  {
                        "order":  10030.0,
                        "parentTag":  "us-gaap_OperatingLeaseRightOfUseAsset",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Operating lease right of use asset non current.",
                            "label":  "Operating Lease Right Of Use Asset Non Current",
                            "terseLabel":  "Operating lease right-of-use assets"
                            }
                        }
                    },
                "localname":  "OperatingLeaseRightOfUseAssetNonCurrent",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "onvo_OperatingLeaseTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Operating lease disclosure.",
                            "label":  "Operating Lease [Table]",
                            "terseLabel":  "Operating Lease [Table]"
                            }
                        }
                    },
                "localname":  "OperatingLeaseTable",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "onvo_OperatingLeasesMonthlyRentExpense":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Operating leases monthly rent expense.",
                            "label":  "Operating Leases Monthly Rent Expense",
                            "terseLabel":  "Monthly rental payments"
                            }
                        }
                    },
                "localname":  "OperatingLeasesMonthlyRentExpense",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "onvo_PercentageOfRoyaltyRevenueFromSublicensee":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of royalty revenue from sublicensee.",
                            "label":  "Percentage Of Royalty Revenue From Sublicensee",
                            "terseLabel":  "Percentage of royalty revenue from sublicensee"
                            }
                        }
                    },
                "localname":  "PercentageOfRoyaltyRevenueFromSublicensee",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail"
                    ],
                "xbrltype":  "percentItemType"
                },
            "onvo_ProspectusTo2021ShelfMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Prospectus to the 2021 Shelf.",
                            "label":  "Prospectus To2021 Shelf [Member]",
                            "terseLabel":  "ATM Prospectus Supplement [Member]"
                            }
                        }
                    },
                "localname":  "ProspectusTo2021ShelfMember",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "onvo_RoyaltyFeesPercentageMaximum":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Royalty fees percentage maximum.",
                            "label":  "Royalty Fees Percentage Maximum",
                            "terseLabel":  "Royalty fees percentage maximum"
                            }
                        }
                    },
                "localname":  "RoyaltyFeesPercentageMaximum",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail"
                    ],
                "xbrltype":  "percentItemType"
                },
            "onvo_RoyaltyFeesPercentageMinimum":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Royalty fees percentage minimum.",
                            "label":  "Royalty Fees Percentage Minimum",
                            "terseLabel":  "Royalty fees percentage minimum"
                            }
                        }
                    },
                "localname":  "RoyaltyFeesPercentageMinimum",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail"
                    ],
                "xbrltype":  "percentItemType"
                },
            "onvo_RoyaltyPaymentsUnderLicenseAgreementDueYearTwo":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Royalty payments under license agreement due year two.",
                            "label":  "Royalty Payments Under License Agreement Due Year Two",
                            "terseLabel":  "Minimum annual royalty payment due"
                            }
                        }
                    },
                "localname":  "RoyaltyPaymentsUnderLicenseAgreementDueYearTwo",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "onvo_SanDiegoPermanentLeaseMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "San Diego permanent lease.",
                            "label":  "San Diego Permanent Lease [Member]",
                            "terseLabel":  "San Diego Permanent Lease [Member]"
                            }
                        }
                    },
                "localname":  "SanDiegoPermanentLeaseMember",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "onvo_SanDiegoTemporaryLeaseMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "San Diego temporary lease.",
                            "label":  "San Diego Temporary Lease [Member]",
                            "terseLabel":  "San Diego Temporary Lease [Member]"
                            }
                        }
                    },
                "localname":  "SanDiegoTemporaryLeaseMember",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "onvo_ScheduleOfInvestmentsInEquitySecuritiesMeasuredAtFairValueLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule of investments in equity securities measured at fair value.",
                            "label":  "Schedule Of Investments In Equity Securities Measured At Fair Value [Line Items]",
                            "terseLabel":  "Schedule of Investments in Equity Securities Measured at Fair Value [Line Items)"
                            }
                        }
                    },
                "localname":  "ScheduleOfInvestmentsInEquitySecuritiesMeasuredAtFairValueLineItems",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfActivityForInvestmentsInEquitySecuritiesMeasuredAtFairValueDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "onvo_ScheduleOfInvestmentsInEquitySecuritiesMeasuredAtFairValueTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule of investments in equity securities measured at fair value.",
                            "label":  "Schedule Of Investments In Equity Securities Measured At Fair Value Table [Text Block]",
                            "terseLabel":  "Schedule of Activity for Investments in Equity Securities Measured at Fair Value"
                            }
                        }
                    },
                "localname":  "ScheduleOfInvestmentsInEquitySecuritiesMeasuredAtFairValueTableTextBlock",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "onvo_ScheduleOfSummaryOfSignificantAccountingPolicyTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule of summary of significant accounting policy.",
                            "label":  "Schedule Of Summary Of Significant Accounting Policy [Table]",
                            "terseLabel":  "Schedule Of Summary Of Significant Accounting Policy [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfSummaryOfSignificantAccountingPolicyTable",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfActivityForInvestmentsInEquitySecuritiesMeasuredAtFairValueDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "onvo_ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialOfferingPeriod":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share based compensation arrangement by share based payment award initial offering period.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Initial Offering Period",
                            "terseLabel":  "Initial offering period"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialOfferingPeriod",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "gYearMonthItemType"
                },
            "onvo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share based compensation arrangement by share based payment award maximum amount per employee.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Maximum Amount Per Employee",
                            "terseLabel":  "Compensation amount per employee"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "onvo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share based compensation arrangement by share based payment award purchase period.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Purchase Period",
                            "terseLabel":  "Purchase period"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "durationItemType"
                },
            "onvo_StockIssuedDuringPeriodSharesPublicOffering":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock issued during period shares public offering.",
                            "label":  "Stock Issued During Period Shares Public Offering",
                            "terseLabel":  "Issuance of common stock from public offering, Shares"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesPublicOffering",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "onvo_StockIssuedDuringPeriodSharesUnderEmployeeAndDirectorStockOptionRSUAndPurchasePlans":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock issued during period shares under employee and director stock option RSU and purchase plans.",
                            "label":  "Stock Issued During Period Shares Under Employee And Director Stock Option R S U And Purchase Plans",
                            "terseLabel":  "Issuance of common stock under employee and director stock option, restricted stock units, and purchase plans, Shares"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesUnderEmployeeAndDirectorStockOptionRSUAndPurchasePlans",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "onvo_StockIssuedDuringPeriodValuePublicOffering":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock issued during period value public offering.",
                            "label":  "Stock Issued During Period Value Public Offering",
                            "terseLabel":  "Issuance of common stock from public offering, net"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValuePublicOffering",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "onvo_StockIssuedDuringPeriodValueUnderEmployeeAndDirectorStockOptionRSUAndPurchasePlans":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock issued during period value under employee and director stock option RSU and purchase plans.",
                            "label":  "Stock Issued During Period Value Under Employee And Director Stock Option R S U And Purchase Plans",
                            "terseLabel":  "Issuance of common stock under employee and director stock option, RSU, and purchase plans"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueUnderEmployeeAndDirectorStockOptionRSUAndPurchasePlans",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "onvo_SublicenseAgreementsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sublicense agreements.",
                            "label":  "Sublicense Agreements [Member]",
                            "terseLabel":  "Sublicense Agreements [Member]"
                            }
                        }
                    },
                "localname":  "SublicenseAgreementsMember",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "onvo_SummaryOfSignificantAccountingPoliciesLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Summary of significant accounting policies.",
                            "label":  "Summary Of Significant Accounting Policies [Line Items]",
                            "terseLabel":  "Summary Of Significant Accounting Policies [Line Items]"
                            }
                        }
                    },
                "localname":  "SummaryOfSignificantAccountingPoliciesLineItems",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "onvo_ThreeMonthTreasuryBillsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Three month treasury bills.",
                            "label":  "Three Month Treasury Bills [Member]",
                            "terseLabel":  "Three Month Treasury Bills [Member]"
                            }
                        }
                    },
                "localname":  "ThreeMonthTreasuryBillsMember",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "onvo_TwoThousandAndTwentyOneInducementEquityPlanMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Two thousand and twenty one inducement equity plan.",
                            "label":  "Two Thousand And Twenty One Inducement Equity Plan [Member]",
                            "terseLabel":  "2021 Inducement Equity Plan [Member]"
                            }
                        }
                    },
                "localname":  "TwoThousandAndTwentyOneInducementEquityPlanMember",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "onvo_TwoThousandAndTwentyOneShelfMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Two thousand and twenty one shelf.",
                            "label":  "Two Thousand And Twenty One Shelf [Member]",
                            "terseLabel":  "2021 Shelf [Member]"
                            }
                        }
                    },
                "localname":  "TwoThousandAndTwentyOneShelfMember",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "onvo_TwoThousandEighteenSalesAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "2018 sales agreement.",
                            "label":  "Two Thousand Eighteen Sales Agreement [Member]",
                            "terseLabel":  "2018 Sales Agreement [Member]"
                            }
                        }
                    },
                "localname":  "TwoThousandEighteenSalesAgreementMember",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "onvo_TwoThousandTwelvePlanMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Two thousand twelve plan.",
                            "label":  "Two Thousand Twelve Plan [Member]",
                            "terseLabel":  "2012 Plan [Member]"
                            }
                        }
                    },
                "localname":  "TwoThousandTwelvePlanMember",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "onvo_UniversityOfMissouriMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "University of Missouri.",
                            "label":  "University Of Missouri [Member]",
                            "terseLabel":  "University of Missouri [Member]"
                            }
                        }
                    },
                "localname":  "UniversityOfMissouriMember",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "onvo_UpfrontFeePayment":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Upfront fee payment.",
                            "label":  "Upfront Fee Payment",
                            "terseLabel":  "Upfront payment"
                            }
                        }
                    },
                "localname":  "UpfrontFeePayment",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "onvo_VestingCriteriaProbabilityOfAchievementPercentage":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Vesting criteria probability of achievement percentage.",
                            "label":  "Vesting Criteria Probability Of Achievement Percentage",
                            "terseLabel":  "Vesting criteria probability of achievement percentage"
                            }
                        }
                    },
                "localname":  "VestingCriteriaProbabilityOfAchievementPercentage",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "percentItemType"
                },
            "onvo_ViscientBiosciencesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Viscient Biosciences.",
                            "label":  "Viscient Biosciences [Member]",
                            "terseLabel":  "Viscient [Member]"
                            }
                        }
                    },
                "localname":  "ViscientBiosciencesMember",
                "nsuri":  "http://www.organovo.com/20220930",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_MaximumMember":  {
                "auth_ref":  [
                    "r144",
                    "r145",
                    "r146",
                    "r147",
                    "r159",
                    "r168",
                    "r206",
                    "r207",
                    "r327",
                    "r328",
                    "r329",
                    "r330",
                    "r331",
                    "r332",
                    "r333",
                    "r371",
                    "r372",
                    "r394",
                    "r395"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Maximum [Member]",
                            "terseLabel":  "Maximum [Member]"
                            }
                        }
                    },
                "localname":  "MaximumMember",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_MinimumMember":  {
                "auth_ref":  [
                    "r144",
                    "r145",
                    "r146",
                    "r147",
                    "r159",
                    "r168",
                    "r206",
                    "r207",
                    "r327",
                    "r328",
                    "r329",
                    "r330",
                    "r331",
                    "r332",
                    "r333",
                    "r371",
                    "r372",
                    "r394",
                    "r395"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Minimum [Member]",
                            "terseLabel":  "Minimum [Member]"
                            }
                        }
                    },
                "localname":  "MinimumMember",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_RangeAxis":  {
                "auth_ref":  [
                    "r141",
                    "r144",
                    "r145",
                    "r146",
                    "r147",
                    "r159",
                    "r168",
                    "r196",
                    "r206",
                    "r207",
                    "r240",
                    "r241",
                    "r242",
                    "r327",
                    "r328",
                    "r329",
                    "r330",
                    "r331",
                    "r332",
                    "r333",
                    "r371",
                    "r372",
                    "r394",
                    "r395"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Range [Axis]",
                            "terseLabel":  "Statistical Measurement"
                            }
                        }
                    },
                "localname":  "RangeAxis",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_RangeMember":  {
                "auth_ref":  [
                    "r141",
                    "r144",
                    "r145",
                    "r146",
                    "r147",
                    "r159",
                    "r168",
                    "r196",
                    "r206",
                    "r207",
                    "r240",
                    "r241",
                    "r242",
                    "r327",
                    "r328",
                    "r329",
                    "r330",
                    "r331",
                    "r332",
                    "r333",
                    "r371",
                    "r372",
                    "r394",
                    "r395"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Range [Member]",
                            "terseLabel":  "Statistical Measurement"
                            }
                        }
                    },
                "localname":  "RangeMember",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_TitleOfIndividualAxis":  {
                "auth_ref":  [
                    "r122",
                    "r317"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Title Of Individual [Axis]",
                            "terseLabel":  "Title of Individual"
                            }
                        }
                    },
                "localname":  "TitleOfIndividualAxis",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_TitleOfIndividualWithRelationshipToEntityDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Title Of Individual With Relationship To Entity [Domain]",
                            "terseLabel":  "Title of Individual"
                            }
                        }
                    },
                "localname":  "TitleOfIndividualWithRelationshipToEntityDomain",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AccountingPoliciesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accounting Policies [Abstract]"
                            }
                        }
                    },
                "localname":  "AccountingPoliciesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AccountsPayableCurrent":  {
                "auth_ref":  [
                    "r21",
                    "r323"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  10090.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accounts Payable Current",
                            "terseLabel":  "Accounts payable"
                            }
                        }
                    },
                "localname":  "AccountsPayableCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r23"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  10100.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.  Examples include taxes, interest, rent and utilities.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued Liabilities Current",
                            "terseLabel":  "Accrued expenses"
                            }
                        }
                    },
                "localname":  "AccruedLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdditionalPaidInCapitalCommonStock":  {
                "auth_ref":  [
                    "r14"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  10040.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions.  Includes only common stock transactions (excludes preferred stock transactions).  May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
                            "label":  "Additional Paid In Capital Common Stock",
                            "terseLabel":  "Additional paid-in capital"
                            }
                        }
                    },
                "localname":  "AdditionalPaidInCapitalCommonStock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdditionalPaidInCapitalMember":  {
                "auth_ref":  [
                    "r66",
                    "r67",
                    "r68",
                    "r248",
                    "r249",
                    "r250",
                    "r282"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
                            "label":  "Additional Paid In Capital [Member]",
                            "terseLabel":  "Additional Paid-in Capital [Member]"
                            }
                        }
                    },
                "localname":  "AdditionalPaidInCapitalMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue":  {
                "auth_ref":  [
                    "r209",
                    "r252",
                    "r253"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
                            "label":  "Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value",
                            "terseLabel":  "Stock-based compensation expense"
                            }
                        }
                    },
                "localname":  "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]",
                            "terseLabel":  "Adjustments to reconcile net loss to net cash used in operating activities:"
                            }
                        }
                    },
                "localname":  "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AllocatedShareBasedCompensationExpense":  {
                "auth_ref":  [
                    "r245"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  10140.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of expense for award under share-based payment arrangement.  Excludes amount capitalized.",
                            "label":  "Allocated Share Based Compensation Expense",
                            "terseLabel":  "Stock-based compensation",
                            "verboseLabel":  "Total stock-based compensation expense"
                            }
                        }
                    },
                "localname":  "AllocatedShareBasedCompensationExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockBasedCompensationExpenseDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":  {
                "auth_ref":  [
                    "r86"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
                            "label":  "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount",
                            "terseLabel":  "Common stock equivalents excluded from computing diluted net loss per share"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_Assets":  {
                "auth_ref":  [
                    "r9",
                    "r63",
                    "r108",
                    "r111",
                    "r117",
                    "r129",
                    "r148",
                    "r149",
                    "r150",
                    "r151",
                    "r152",
                    "r153",
                    "r154",
                    "r155",
                    "r156",
                    "r157",
                    "r158",
                    "r273",
                    "r277",
                    "r287",
                    "r321",
                    "r323",
                    "r351",
                    "r362"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized.  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets",
                            "totalLabel":  "Total assets"
                            }
                        }
                    },
                "localname":  "Assets",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Assets [Abstract]",
                            "terseLabel":  "Assets"
                            }
                        }
                    },
                "localname":  "AssetsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails",
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AssetsCurrent":  {
                "auth_ref":  [
                    "r5",
                    "r20",
                    "r63",
                    "r129",
                    "r148",
                    "r149",
                    "r150",
                    "r151",
                    "r152",
                    "r153",
                    "r154",
                    "r155",
                    "r156",
                    "r157",
                    "r158",
                    "r273",
                    "r277",
                    "r287",
                    "r321",
                    "r323"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  10120.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer).  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets Current",
                            "totalLabel":  "Total current assets"
                            }
                        }
                    },
                "localname":  "AssetsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsCurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Assets Current [Abstract]",
                            "terseLabel":  "Current Assets"
                            }
                        }
                    },
                "localname":  "AssetsCurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AwardTypeAxis":  {
                "auth_ref":  [
                    "r213",
                    "r214",
                    "r215",
                    "r217",
                    "r218",
                    "r219",
                    "r220",
                    "r221",
                    "r222",
                    "r223",
                    "r224",
                    "r226",
                    "r227",
                    "r228",
                    "r229",
                    "r230",
                    "r231",
                    "r233",
                    "r234",
                    "r236",
                    "r237",
                    "r239",
                    "r240",
                    "r241",
                    "r242",
                    "r243"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of award under share-based payment arrangement.",
                            "label":  "Award Type [Axis]",
                            "terseLabel":  "Award Type"
                            }
                        }
                    },
                "localname":  "AwardTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockBasedCompensationExpenseAndValuationInformationAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanySRsusActivityAndPerformanceBasedRsusActivityDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityTables"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CashAndCashEquivalentsAtCarryingValue":  {
                "auth_ref":  [
                    "r3",
                    "r7",
                    "r57"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  10170.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of currency on hand as well as demand deposits with banks or financial institutions.  Includes other kinds of accounts that have the general characteristics of demand deposits.  Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.  Excludes cash and cash equivalents within disposal group and discontinued operation.",
                            "label":  "Cash And Cash Equivalents At Carrying Value",
                            "periodEndLabel":  "Cash and cash equivalents",
                            "terseLabel":  "Cash and cash equivalents",
                            "verboseLabel":  "Cash and cash equivalents"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsAtCarryingValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets",
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]",
                            "terseLabel":  "Reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations":  {
                "auth_ref":  [
                    "r51",
                    "r57",
                    "r59"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations",
                            "periodEndLabel":  "Cash, cash equivalents, and restricted cash at end of period",
                            "periodStartLabel":  "Cash, cash equivalents, and restricted cash at beginning of period"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect":  {
                "auth_ref":  [
                    "r51",
                    "r288"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect",
                            "totalLabel":  "Net decrease in cash, cash equivalents, and restricted cash"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ClassOfStockLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Class Of Stock [Line Items]",
                            "terseLabel":  "Class Of Stock [Line Items]"
                            }
                        }
                    },
                "localname":  "ClassOfStockLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockBasedCompensationExpenseAndValuationInformationAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanySRsusActivityAndPerformanceBasedRsusActivityDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityTables"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CollaborativeArrangementDisclosureTextBlock":  {
                "auth_ref":  [
                    "r266",
                    "r267",
                    "r269"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
                            "label":  "Collaborative Arrangement Disclosure [Text Block]",
                            "terseLabel":  "Collaborative Research, Development, and License Agreements"
                            }
                        }
                    },
                "localname":  "CollaborativeArrangementDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreements"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]",
                            "terseLabel":  "Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]"
                            }
                        }
                    },
                "localname":  "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CommitmentsAndContingenciesDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Commitments And Contingencies Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingenciesDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CommitmentsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r143"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements.  Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.",
                            "label":  "Commitments Disclosure [Text Block]",
                            "terseLabel":  "Commitments and Contingencies"
                            }
                        }
                    },
                "localname":  "CommitmentsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingencies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance":  {
                "auth_ref":  [
                    "r25"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate number of common shares reserved for future issuance.",
                            "label":  "Common Stock Capital Shares Reserved For Future Issuance",
                            "terseLabel":  "Common stock reserved for future issuance",
                            "verboseLabel":  "Number of common stock shares approved under ESPP"
                            }
                        }
                    },
                "localname":  "CommonStockCapitalSharesReservedForFutureIssuance",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockMember":  {
                "auth_ref":  [
                    "r66",
                    "r67",
                    "r282"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock that is subordinate to all other stock of the issuer.",
                            "label":  "Common Stock [Member]",
                            "terseLabel":  "Common Stock [Member]"
                            }
                        }
                    },
                "localname":  "CommonStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CommonStockParOrStatedValuePerShare":  {
                "auth_ref":  [
                    "r13"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Face amount or stated value per share of common stock.",
                            "label":  "Common Stock Par Or Stated Value Per Share",
                            "terseLabel":  "Common stock, par value"
                            }
                        }
                    },
                "localname":  "CommonStockParOrStatedValuePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_CommonStockSharesAuthorized":  {
                "auth_ref":  [
                    "r13"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
                            "label":  "Common Stock Shares Authorized",
                            "terseLabel":  "Common stock, shares authorized"
                            }
                        }
                    },
                "localname":  "CommonStockSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockSharesIssued":  {
                "auth_ref":  [
                    "r13"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury).  These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized.  Shares issued include shares outstanding and shares held in the treasury.",
                            "label":  "Common Stock Shares Issued",
                            "terseLabel":  "Common stock, shares issued",
                            "verboseLabel":  "Issuance of common stock"
                            }
                        }
                    },
                "localname":  "CommonStockSharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockSharesOutstanding":  {
                "auth_ref":  [
                    "r13",
                    "r173"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares of common stock outstanding.  Common stock represent the ownership interest in a corporation.",
                            "label":  "Common Stock Shares Outstanding",
                            "terseLabel":  "Common stock, shares outstanding"
                            }
                        }
                    },
                "localname":  "CommonStockSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockValue":  {
                "auth_ref":  [
                    "r13",
                    "r323"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  10030.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer).  This item includes treasury stock repurchased by the entity.  Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
                            "label":  "Common Stock Value",
                            "terseLabel":  "Common stock, $0.001 par value; 200,000,000 shares authorized, 8,713,268 and 8,710,627 shares issued and outstanding at September 30, 2022 and March 31, 2022, respectively"
                            }
                        }
                    },
                "localname":  "CommonStockValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ComprehensiveIncomeNetOfTax":  {
                "auth_ref":  [
                    "r30",
                    "r32",
                    "r33",
                    "r38",
                    "r356",
                    "r367"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity.  Excludes changes in equity resulting from investments by owners and distributions to owners.",
                            "label":  "Comprehensive Income Net Of Tax",
                            "totalLabel":  "Comprehensive loss"
                            }
                        }
                    },
                "localname":  "ComprehensiveIncomeNetOfTax",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ComprehensiveIncomeNetOfTaxAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Comprehensive Income Net Of Tax [Abstract]",
                            "terseLabel":  "Comprehensive Loss:"
                            }
                        }
                    },
                "localname":  "ComprehensiveIncomeNetOfTaxAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ConcentrationRiskDisclosureTextBlock":  {
                "auth_ref":  [
                    "r102"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact.  This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
                            "label":  "Concentration Risk Disclosure [Text Block]",
                            "terseLabel":  "Concentrations"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureConcentrations"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_DebtSecuritiesUnrealizedGainLoss":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in net income (trading).",
                            "label":  "Debt Securities Unrealized Gain Loss",
                            "terseLabel":  "Unrealized gains or losses on short-term investments"
                            }
                        }
                    },
                "localname":  "DebtSecuritiesUnrealizedGainLoss",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DepreciationDepletionAndAmortization":  {
                "auth_ref":  [
                    "r55",
                    "r106"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  10130.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
                            "label":  "Depreciation Depletion And Amortization",
                            "terseLabel":  "Depreciation and amortization"
                            }
                        }
                    },
                "localname":  "DepreciationDepletionAndAmortization",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DilutiveSecurities":  {
                "auth_ref":  [
                    "r87"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities.",
                            "label":  "Dilutive Securities",
                            "terseLabel":  "Dilutive effect"
                            }
                        }
                    },
                "localname":  "DilutiveSecurities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DisaggregationOfRevenueAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Disaggregation Of Revenue [Abstract]",
                            "terseLabel":  "Revenues"
                            }
                        }
                    },
                "localname":  "DisaggregationOfRevenueAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]"
                            }
                        }
                    },
                "localname":  "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EarningsPerShareBasic":  {
                "auth_ref":  [
                    "r39",
                    "r71",
                    "r72",
                    "r73",
                    "r74",
                    "r75",
                    "r79",
                    "r81",
                    "r83",
                    "r84",
                    "r85",
                    "r89",
                    "r90",
                    "r283",
                    "r284",
                    "r357",
                    "r368"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
                            "label":  "Earnings Per Share Basic",
                            "terseLabel":  "Net loss per common share basic"
                            }
                        }
                    },
                "localname":  "EarningsPerShareBasic",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_EarningsPerShareDiluted":  {
                "auth_ref":  [
                    "r39",
                    "r71",
                    "r72",
                    "r73",
                    "r74",
                    "r75",
                    "r81",
                    "r83",
                    "r84",
                    "r85",
                    "r89",
                    "r90",
                    "r283",
                    "r284",
                    "r357",
                    "r368"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
                            "label":  "Earnings Per Share Diluted",
                            "terseLabel":  "Net loss per common share diluted"
                            }
                        }
                    },
                "localname":  "EarningsPerShareDiluted",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_EarningsPerSharePolicyTextBlock":  {
                "auth_ref":  [
                    "r86",
                    "r88"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security.  Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
                            "label":  "Earnings Per Share Policy [Text Block]",
                            "terseLabel":  "Net Loss Per Share"
                            }
                        }
                    },
                "localname":  "EarningsPerSharePolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]",
                            "terseLabel":  "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]"
                            }
                        }
                    },
                "localname":  "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockBasedCompensationExpenseDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1":  {
                "auth_ref":  [
                    "r246"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1",
                            "terseLabel":  "Total unrecognized compensation cost related, weighted average period"
                            }
                        }
                    },
                "localname":  "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockBasedCompensationExpenseAndValuationInformationAdditionalInformationDetail"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions":  {
                "auth_ref":  [
                    "r246"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cost to be recognized for nonvested award under share-based payment arrangement.  Excludes share and unit options.",
                            "label":  "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options",
                            "terseLabel":  "Unrecognized stock-based compensation expense"
                            }
                        }
                    },
                "localname":  "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockBasedCompensationExpenseAndValuationInformationAdditionalInformationDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions":  {
                "auth_ref":  [
                    "r246"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cost to be recognized for option under share-based payment arrangement.",
                            "label":  "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options",
                            "terseLabel":  "Total unrecognized compensation cost related to unvested stock option grants"
                            }
                        }
                    },
                "localname":  "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockBasedCompensationExpenseAndValuationInformationAdditionalInformationDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EmployeeStockOptionMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
                            "label":  "Employee Stock Option [Member]",
                            "terseLabel":  "Stock options [Member]"
                            }
                        }
                    },
                "localname":  "EmployeeStockOptionMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockBasedCompensationExpenseAndValuationInformationAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis":  {
                "auth_ref":  [
                    "r255"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by name of employee stock ownership plan.",
                            "label":  "Employee Stock Ownership Plan E S O P Disclosures By Plan [Axis]",
                            "terseLabel":  "Employee Stock Ownership Plan (ESOP) Name"
                            }
                        }
                    },
                "localname":  "EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityFairValueOfESPPSharesDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityTables"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain":  {
                "auth_ref":  [
                    "r254"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Entities identify multiple employee stock ownership plans by unique name.",
                            "label":  "Employee Stock Ownership Plan E S O P Plan [Domain]",
                            "terseLabel":  "Employee Stock Ownership Plan (ESOP), Plan"
                            }
                        }
                    },
                "localname":  "EmployeeStockOwnershipPlanESOPPlanDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityFairValueOfESPPSharesDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityTables"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_EquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity [Abstract]"
                            }
                        }
                    },
                "localname":  "EquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EquityComponentDomain":  {
                "auth_ref":  [
                    "r0",
                    "r34",
                    "r35",
                    "r36",
                    "r66",
                    "r67",
                    "r68",
                    "r70",
                    "r76",
                    "r78",
                    "r91",
                    "r132",
                    "r173",
                    "r180",
                    "r248",
                    "r249",
                    "r250",
                    "r261",
                    "r262",
                    "r282",
                    "r289",
                    "r290",
                    "r291",
                    "r292",
                    "r293",
                    "r294",
                    "r311",
                    "r373",
                    "r374",
                    "r375"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
                            "label":  "Equity Component [Domain]",
                            "terseLabel":  "Equity Component"
                            }
                        }
                    },
                "localname":  "EquityComponentDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_EquitySecuritiesFVNIAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity Securities F V N I [Abstract]"
                            }
                        }
                    },
                "localname":  "EquitySecuritiesFVNIAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EquitySecuritiesFVNINoncurrent":  {
                "auth_ref":  [
                    "r286"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as noncurrent.",
                            "label":  "Equity Securities F V N I Noncurrent",
                            "periodEndLabel":  "Balance at September 30, 2022",
                            "periodStartLabel":  "Balance at March 31, 2022"
                            }
                        }
                    },
                "localname":  "EquitySecuritiesFVNINoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfActivityForInvestmentsInEquitySecuritiesMeasuredAtFairValueDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EquitySecuritiesFvNi":  {
                "auth_ref":  [
                    "r4",
                    "r10",
                    "r286"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
                            "label":  "Equity Securities Fv Ni",
                            "terseLabel":  "Fair value of investment in equity securities"
                            }
                        }
                    },
                "localname":  "EquitySecuritiesFvNi",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EquitySecuritiesFvNiGainLoss":  {
                "auth_ref":  [
                    "r126"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  10110.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        },
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "order":  10050.0,
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
                            "label":  "Equity Securities Fv Ni Gain Loss",
                            "negatedLabel":  "Loss on investment in equity securities",
                            "terseLabel":  "Loss on investment in equity securities",
                            "verboseLabel":  "Loss on investment in equity securities"
                            }
                        }
                    },
                "localname":  "EquitySecuritiesFvNiGainLoss",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfActivityForInvestmentsInEquitySecuritiesMeasuredAtFairValueDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows",
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EquitySecuritiesFvNiUnrealizedLoss":  {
                "auth_ref":  [
                    "r126"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
                            "label":  "Equity Securities Fv Ni Unrealized Loss",
                            "terseLabel":  "Unrealized loss on investment in equity securities"
                            }
                        }
                    },
                "localname":  "EquitySecuritiesFvNiUnrealizedLoss",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FairValueByFairValueHierarchyLevelAxis":  {
                "auth_ref":  [
                    "r160",
                    "r161",
                    "r162",
                    "r197",
                    "r198",
                    "r199",
                    "r200",
                    "r201",
                    "r202",
                    "r203",
                    "r205",
                    "r285",
                    "r324",
                    "r325",
                    "r326"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
                            "label":  "Fair Value By Fair Value Hierarchy Level [Axis]",
                            "terseLabel":  "Fair Value Hierarchy and NAV"
                            }
                        }
                    },
                "localname":  "FairValueByFairValueHierarchyLevelAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfActivityForInvestmentsInEquitySecuritiesMeasuredAtFairValueDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FairValueInputsLevel1Member":  {
                "auth_ref":  [
                    "r160",
                    "r197",
                    "r198",
                    "r203",
                    "r205",
                    "r285",
                    "r324"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
                            "label":  "Fair Value Inputs Level1 [Member]",
                            "terseLabel":  "Level 1 [Member]"
                            }
                        }
                    },
                "localname":  "FairValueInputsLevel1Member",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfActivityForInvestmentsInEquitySecuritiesMeasuredAtFairValueDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueMeasurementPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity.  Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
                            "label":  "Fair Value Measurement Policy Policy [Text Block]",
                            "terseLabel":  "Fair value measurement"
                            }
                        }
                    },
                "localname":  "FairValueMeasurementPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FairValueMeasurementsFairValueHierarchyDomain":  {
                "auth_ref":  [
                    "r160",
                    "r161",
                    "r162",
                    "r197",
                    "r198",
                    "r199",
                    "r200",
                    "r201",
                    "r202",
                    "r203",
                    "r205",
                    "r324",
                    "r325",
                    "r326"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
                            "label":  "Fair Value Measurements Fair Value Hierarchy [Domain]",
                            "terseLabel":  "Fair Value Hierarchy and NAV"
                            }
                        }
                    },
                "localname":  "FairValueMeasurementsFairValueHierarchyDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfActivityForInvestmentsInEquitySecuritiesMeasuredAtFairValueDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis":  {
                "auth_ref":  [
                    "r133",
                    "r134",
                    "r136",
                    "r137",
                    "r336",
                    "r337"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by major type or class of finite-lived intangible assets.",
                            "label":  "Finite Lived Intangible Assets By Major Class [Axis]",
                            "terseLabel":  "Finite-Lived Intangible Assets by Major Class"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsByMajorClassAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain":  {
                "auth_ref":  [
                    "r133",
                    "r135"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
                            "label":  "Finite Lived Intangible Assets Major Class Name [Domain]",
                            "terseLabel":  "Finite-Lived Intangible Assets, Major Class Name"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsMajorClassNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_GeneralAndAdministrativeExpenseMember":  {
                "auth_ref":  [
                    "r40"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Primary financial statement caption encompassing general and administrative expense.",
                            "label":  "General And Administrative Expense [Member]",
                            "terseLabel":  "General and administrative"
                            }
                        }
                    },
                "localname":  "GeneralAndAdministrativeExpenseMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockBasedCompensationExpenseDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_IPOMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "First sale of stock by a private company to the public.",
                            "label":  "I P O [Member]",
                            "terseLabel":  "IPO [Member]"
                            }
                        }
                    },
                "localname":  "IPOMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_IncomeStatementAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Statement [Abstract]"
                            }
                        }
                    },
                "localname":  "IncomeStatementAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeStatementLocationAxis":  {
                "auth_ref":  [
                    "r140",
                    "r142"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by location in the income statement.",
                            "label":  "Income Statement Location [Axis]",
                            "terseLabel":  "Income Statement Location"
                            }
                        }
                    },
                "localname":  "IncomeStatementLocationAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockBasedCompensationExpenseDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeStatementLocationDomain":  {
                "auth_ref":  [
                    "r142"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Location in the income statement.",
                            "label":  "Income Statement Location [Domain]",
                            "terseLabel":  "Income Statement Location"
                            }
                        }
                    },
                "localname":  "IncomeStatementLocationDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockBasedCompensationExpenseDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_IncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r64",
                    "r77",
                    "r78",
                    "r107",
                    "r260",
                    "r263",
                    "r264",
                    "r370"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "order":  10040.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
                            "label":  "Income Tax Expense Benefit",
                            "negatedLabel":  "Income Tax Expense"
                            }
                        }
                    },
                "localname":  "IncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeTaxesPaid":  {
                "auth_ref":  [
                    "r52",
                    "r58"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
                            "label":  "Income Taxes Paid",
                            "negatedLabel":  "Income taxes paid"
                            }
                        }
                    },
                "localname":  "IncomeTaxesPaid",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccountsPayable":  {
                "auth_ref":  [
                    "r54"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  10160.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
                            "label":  "Increase Decrease In Accounts Payable",
                            "terseLabel":  "Accounts payable"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccountsPayable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccruedLiabilities":  {
                "auth_ref":  [
                    "r54"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  10170.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
                            "label":  "Increase Decrease In Accrued Liabilities",
                            "terseLabel":  "Accrued expenses"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccruedLiabilities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Increase Decrease In Operating Capital [Abstract]",
                            "terseLabel":  "Increase (decrease) in cash resulting from changes in:"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOperatingCapitalAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets":  {
                "auth_ref":  [
                    "r54"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  10150.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
                            "label":  "Increase Decrease In Prepaid Deferred Expense And Other Assets",
                            "negatedLabel":  "Prepaid expenses and other assets"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InvestmentIncomeInterest":  {
                "auth_ref":  [
                    "r42",
                    "r105"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "order":  10060.0,
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
                            "label":  "Investment Income Interest",
                            "terseLabel":  "Interest income"
                            }
                        }
                    },
                "localname":  "InvestmentIncomeInterest",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InvestmentPolicyTextBlock":  {
                "auth_ref":  [
                    "r128",
                    "r369"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for investment in financial asset.",
                            "label":  "Investment Policy [Text Block]",
                            "terseLabel":  "Investments"
                            }
                        }
                    },
                "localname":  "InvestmentPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_InvestmentTextBlock":  {
                "auth_ref":  [
                    "r124",
                    "r127",
                    "r130",
                    "r131"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for investment.",
                            "label":  "Investment [Text Block]",
                            "terseLabel":  "Investments"
                            }
                        }
                    },
                "localname":  "InvestmentTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureInvestments"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_InvestmentTypeAxis":  {
                "auth_ref":  [
                    "r378",
                    "r379",
                    "r380",
                    "r381",
                    "r382",
                    "r383",
                    "r384",
                    "r385",
                    "r386",
                    "r387",
                    "r388",
                    "r389",
                    "r390",
                    "r391",
                    "r392"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of investments.",
                            "label":  "Investment Type [Axis]",
                            "terseLabel":  "Investment Type"
                            }
                        }
                    },
                "localname":  "InvestmentTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_InvestmentTypeCategorizationMember":  {
                "auth_ref":  [
                    "r378",
                    "r379",
                    "r380",
                    "r381",
                    "r382",
                    "r383",
                    "r384",
                    "r385",
                    "r386",
                    "r387",
                    "r388",
                    "r389",
                    "r390",
                    "r391",
                    "r392"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Asset obtained to generate income or appreciate in value.",
                            "label":  "Investment Type Categorization [Member]",
                            "terseLabel":  "Investments"
                            }
                        }
                    },
                "localname":  "InvestmentTypeCategorizationMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_InvestmentsAllOtherInvestmentsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Investments All Other Investments [Abstract]"
                            }
                        }
                    },
                "localname":  "InvestmentsAllOtherInvestmentsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LeaseCostTableTextBlock":  {
                "auth_ref":  [
                    "r307"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of lessee's lease cost.  Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
                            "label":  "Lease Cost Table [Text Block]",
                            "terseLabel":  "Schedule of Lease Liabilities and Corresponding Right-of-use Assets"
                            }
                        }
                    },
                "localname":  "LeaseCostTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LeasesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Leases [Abstract]"
                            }
                        }
                    },
                "localname":  "LeasesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LesseeOperatingLeaseDiscountRate":  {
                "auth_ref":  [
                    "r300"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Discount rate used by lessee to determine present value of operating lease payments.",
                            "label":  "Lessee Operating Lease Discount Rate",
                            "terseLabel":  "Base rent escalators"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseDiscountRate",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock":  {
                "auth_ref":  [
                    "r308"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability.  Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
                            "label":  "Lessee Operating Lease Liability Maturity Table [Text Block]",
                            "terseLabel":  "Schedule of Future Lease Payments"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue":  {
                "auth_ref":  [
                    "r308"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsDetails2":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
                            "label":  "Lessee Operating Lease Liability Payments Due",
                            "totalLabel":  "Total future lease payments"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths":  {
                "auth_ref":  [
                    "r308"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsDetails":  {
                        "order":  10020.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Lessee Operating Lease Liability Payments Due Next Twelve Months",
                            "terseLabel":  "Fiscal year ending March 31, 2024"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour":  {
                "auth_ref":  [
                    "r308"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsDetails":  {
                        "order":  10050.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Lessee Operating Lease Liability Payments Due Year Four",
                            "terseLabel":  "Fiscal year ending March 31, 2027"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree":  {
                "auth_ref":  [
                    "r308"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsDetails":  {
                        "order":  10040.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Lessee Operating Lease Liability Payments Due Year Three",
                            "terseLabel":  "Fiscal year ending March 31, 2026"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo":  {
                "auth_ref":  [
                    "r308"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsDetails":  {
                        "order":  10030.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Lessee Operating Lease Liability Payments Due Year Two",
                            "terseLabel":  "Fiscal year ending March 31, 2025"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear":  {
                "auth_ref":  [
                    "r308"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsDetails":  {
                        "order":  10010.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
                            "label":  "Lessee Operating Lease Liability Payments Remainder Of Fiscal Year",
                            "terseLabel":  "Fiscal year ending March 31, 2023"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount":  {
                "auth_ref":  [
                    "r308"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsDetails2":  {
                        "order":  10010.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
                            "label":  "Lessee Operating Lease Liability Undiscounted Excess Amount",
                            "negatedLabel":  "Less:  Imputed interest"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseTermOfContract":  {
                "auth_ref":  [
                    "r299"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Lessee Operating Lease Term Of Contract",
                            "terseLabel":  "Lease term"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseTermOfContract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_LesseeOperatingLeasesTextBlock":  {
                "auth_ref":  [
                    "r310"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for operating leases of lessee.  Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
                            "label":  "Lessee Operating Leases [Text Block]",
                            "terseLabel":  "Leases"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeasesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeases"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_Liabilities":  {
                "auth_ref":  [
                    "r22",
                    "r63",
                    "r112",
                    "r129",
                    "r148",
                    "r149",
                    "r150",
                    "r152",
                    "r153",
                    "r154",
                    "r155",
                    "r156",
                    "r157",
                    "r158",
                    "r274",
                    "r277",
                    "r278",
                    "r287",
                    "r321",
                    "r322"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  10010.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized.  Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
                            "label":  "Liabilities",
                            "totalLabel":  "Total liabilities"
                            }
                        }
                    },
                "localname":  "Liabilities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesAndStockholdersEquity":  {
                "auth_ref":  [
                    "r18",
                    "r63",
                    "r129",
                    "r287",
                    "r323",
                    "r352",
                    "r364"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
                            "label":  "Liabilities And Stockholders Equity",
                            "totalLabel":  "Total Liabilities and Stockholders\u2019 Equity"
                            }
                        }
                    },
                "localname":  "LiabilitiesAndStockholdersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesAndStockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities And Stockholders Equity [Abstract]",
                            "terseLabel":  "Liabilities and Stockholders\u2019 Equity"
                            }
                        }
                    },
                "localname":  "LiabilitiesAndStockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails",
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LiabilitiesCurrent":  {
                "auth_ref":  [
                    "r6",
                    "r24",
                    "r63",
                    "r129",
                    "r148",
                    "r149",
                    "r150",
                    "r152",
                    "r153",
                    "r154",
                    "r155",
                    "r156",
                    "r157",
                    "r158",
                    "r274",
                    "r277",
                    "r278",
                    "r287",
                    "r321",
                    "r322",
                    "r323"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  10070.0,
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
                            "label":  "Liabilities Current",
                            "totalLabel":  "Total current liabilities"
                            }
                        }
                    },
                "localname":  "LiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesCurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities Current [Abstract]",
                            "terseLabel":  "Current Liabilities"
                            }
                        }
                    },
                "localname":  "LiabilitiesCurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails",
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LiabilitiesNoncurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities Noncurrent [Abstract]",
                            "terseLabel":  "Noncurrent"
                            }
                        }
                    },
                "localname":  "LiabilitiesNoncurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LicensingAgreementsMember":  {
                "auth_ref":  [
                    "r265"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
                            "label":  "Licensing Agreements [Member]",
                            "terseLabel":  "Licensing Agreements [Member]"
                            }
                        }
                    },
                "localname":  "LicensingAgreementsMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_NatureOfOperations":  {
                "auth_ref":  [
                    "r94",
                    "r102"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings.  For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
                            "label":  "Nature Of Operations",
                            "terseLabel":  "Description of Business"
                            }
                        }
                    },
                "localname":  "NatureOfOperations",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureDescriptionOfBusiness"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivities":  {
                "auth_ref":  [
                    "r51"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  10030.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from financing activities, including discontinued operations.  Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
                            "label":  "Net Cash Provided By Used In Financing Activities",
                            "totalLabel":  "Net cash provided by financing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInFinancingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided By Used In Financing Activities [Abstract]",
                            "terseLabel":  "Cash Flows From Financing Activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInFinancingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetCashProvidedByUsedInInvestingActivities":  {
                "auth_ref":  [
                    "r51"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  10020.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from investing activities, including discontinued operations.  Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
                            "label":  "Net Cash Provided By Used In Investing Activities",
                            "totalLabel":  "Net cash used in investing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInInvestingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided By Used In Investing Activities [Abstract]",
                            "terseLabel":  "Cash Flows From Investing Activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInInvestingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivities":  {
                "auth_ref":  [
                    "r51",
                    "r53",
                    "r56"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  10010.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from operating activities, including discontinued operations.  Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
                            "label":  "Net Cash Provided By Used In Operating Activities",
                            "negatedTerseLabel":  "Cash flow from operations",
                            "totalLabel":  "Net cash used in operating activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInOperatingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided By Used In Operating Activities [Abstract]",
                            "terseLabel":  "Cash Flows From Operating Activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInOperatingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetIncomeLoss":  {
                "auth_ref":  [
                    "r2",
                    "r29",
                    "r31",
                    "r36",
                    "r37",
                    "r56",
                    "r63",
                    "r69",
                    "r71",
                    "r72",
                    "r73",
                    "r74",
                    "r77",
                    "r78",
                    "r82",
                    "r108",
                    "r110",
                    "r113",
                    "r116",
                    "r118",
                    "r129",
                    "r148",
                    "r149",
                    "r150",
                    "r152",
                    "r153",
                    "r154",
                    "r155",
                    "r156",
                    "r157",
                    "r158",
                    "r284",
                    "r287",
                    "r355",
                    "r366"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "order":  10010.0,
                        "parentTag":  "us-gaap_ComprehensiveIncomeNetOfTax",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
                            "label":  "Net Income Loss",
                            "terseLabel":  "Net loss",
                            "totalLabel":  "Net Loss"
                            }
                        }
                    },
                "localname":  "NetIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting.  Includes, but is not limited to, quantification of the expected or actual impact.",
                            "label":  "New Accounting Pronouncements Policy Policy [Text Block]",
                            "terseLabel":  "Recent Accounting Pronouncements"
                            }
                        }
                    },
                "localname":  "NewAccountingPronouncementsPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_NonoperatingIncomeExpense":  {
                "auth_ref":  [
                    "r43"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "order":  10030.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
                            "label":  "Nonoperating Income Expense",
                            "totalLabel":  "Total Other Income"
                            }
                        }
                    },
                "localname":  "NonoperatingIncomeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NonoperatingIncomeExpenseAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Nonoperating Income Expense [Abstract]",
                            "terseLabel":  "Other Income (Expense)"
                            }
                        }
                    },
                "localname":  "NonoperatingIncomeExpenseAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OperatingExpenses":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "order":  10090.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services.  Includes selling, general and administrative expense.",
                            "label":  "Operating Expenses",
                            "totalLabel":  "Total costs and expenses"
                            }
                        }
                    },
                "localname":  "OperatingExpenses",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingIncomeLoss":  {
                "auth_ref":  [
                    "r108",
                    "r110",
                    "r113",
                    "r116",
                    "r118"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "order":  10020.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The net result for the period of deducting operating expenses from operating revenues.",
                            "label":  "Operating Income Loss",
                            "totalLabel":  "Loss from Operations"
                            }
                        }
                    },
                "localname":  "OperatingIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseCost":  {
                "auth_ref":  [
                    "r301",
                    "r309"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term.  Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
                            "label":  "Operating Lease Cost",
                            "terseLabel":  "Rent expense"
                            }
                        }
                    },
                "localname":  "OperatingLeaseCost",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseExpense":  {
                "auth_ref":  [
                    "r297"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of operating lease expense.  Excludes sublease income.",
                            "label":  "Operating Lease Expense",
                            "terseLabel":  "Operating Lease, Expense"
                            }
                        }
                    },
                "localname":  "OperatingLeaseExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseLiability":  {
                "auth_ref":  [
                    "r296"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsDetails2":  {
                        "order":  10020.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        },
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease.",
                            "label":  "Operating Lease Liability",
                            "terseLabel":  "Operating lease, liability",
                            "totalLabel":  "Total lease liabilities"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLiability",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsDetails",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseLiabilityCurrent":  {
                "auth_ref":  [
                    "r296"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails":  {
                        "order":  10010.0,
                        "parentTag":  "us-gaap_OperatingLeaseLiability",
                        "weight":  1.0
                        },
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  10110.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
                            "label":  "Operating Lease Liability Current",
                            "negatedLabel":  "Less:  Current obligations",
                            "terseLabel":  "Operating lease liability, current portion"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLiabilityCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsDetails",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails",
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseLiabilityNoncurrent":  {
                "auth_ref":  [
                    "r296"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails":  {
                        "order":  10020.0,
                        "parentTag":  "us-gaap_OperatingLeaseLiability",
                        "weight":  1.0
                        },
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  10080.0,
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
                            "label":  "Operating Lease Liability Noncurrent",
                            "terseLabel":  "Operating lease liability, net of current portion"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLiabilityNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsDetails",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails",
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeasePayments":  {
                "auth_ref":  [
                    "r298",
                    "r304"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
                            "label":  "Operating Lease Payments",
                            "terseLabel":  "Operating cash flows from operating leases"
                            }
                        }
                    },
                "localname":  "OperatingLeasePayments",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseRightOfUseAsset":  {
                "auth_ref":  [
                    "r295"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        },
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  10150.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's right to use underlying asset under operating lease.",
                            "label":  "Operating Lease Right Of Use Asset",
                            "terseLabel":  "Operating lease right-of-use assets",
                            "totalLabel":  "Total lease right-of-use assets"
                            }
                        }
                    },
                "localname":  "OperatingLeaseRightOfUseAsset",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails",
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent":  {
                "auth_ref":  [
                    "r306",
                    "r309"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average discount rate for operating lease calculated at point in time.",
                            "label":  "Operating Lease Weighted Average Discount Rate Percent",
                            "terseLabel":  "Weighted average discount rate:"
                            }
                        }
                    },
                "localname":  "OperatingLeaseWeightedAverageDiscountRatePercent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1":  {
                "auth_ref":  [
                    "r305",
                    "r309"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Operating Lease Weighted Average Remaining Lease Term1",
                            "terseLabel":  "Weighted average remaining lease term:"
                            }
                        }
                    },
                "localname":  "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Organization Consolidation And Presentation Of Financial Statements [Abstract]"
                            }
                        }
                    },
                "localname":  "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OtherCommitmentsAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of other commitment.",
                            "label":  "Other Commitments [Axis]",
                            "terseLabel":  "Other Commitments"
                            }
                        }
                    },
                "localname":  "OtherCommitmentsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OtherCommitmentsDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Other future obligation.",
                            "label":  "Other Commitments [Domain]",
                            "terseLabel":  "Other Commitments"
                            }
                        }
                    },
                "localname":  "OtherCommitmentsDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_OtherNonoperatingIncomeExpense":  {
                "auth_ref":  [
                    "r44"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "order":  10070.0,
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of income (expense) related to nonoperating activities, classified as other.",
                            "label":  "Other Nonoperating Income Expense",
                            "terseLabel":  "Other income"
                            }
                        }
                    },
                "localname":  "OtherNonoperatingIncomeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation":  {
                "auth_ref":  [
                    "r48"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  10050.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
                            "label":  "Payments Related To Tax Withholding For Share Based Compensation",
                            "negatedLabel":  "Employee taxes paid related to net share settlement of equity awards"
                            }
                        }
                    },
                "localname":  "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsToAcquireEquitySecuritiesFvNi":  {
                "auth_ref":  [
                    "r49",
                    "r125"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  10080.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.",
                            "label":  "Payments To Acquire Equity Securities Fv Ni",
                            "negatedLabel":  "Purchases of equity securities",
                            "terseLabel":  "Purchase of equity securities",
                            "verboseLabel":  "Purchases at cost"
                            }
                        }
                    },
                "localname":  "PaymentsToAcquireEquitySecuritiesFvNi",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfActivityForInvestmentsInEquitySecuritiesMeasuredAtFairValueDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment":  {
                "auth_ref":  [
                    "r45"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  10060.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
                            "label":  "Payments To Acquire Property Plant And Equipment",
                            "negatedLabel":  "Purchases of fixed assets"
                            }
                        }
                    },
                "localname":  "PaymentsToAcquirePropertyPlantAndEquipment",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsToAcquireShortTermInvestments":  {
                "auth_ref":  [
                    "r46"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  10070.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle.  Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
                            "label":  "Payments To Acquire Short Term Investments",
                            "negatedLabel":  "Purchases of short-term investments"
                            }
                        }
                    },
                "localname":  "PaymentsToAcquireShortTermInvestments",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PlanNameAxis":  {
                "auth_ref":  [
                    "r213",
                    "r214",
                    "r215",
                    "r217",
                    "r218",
                    "r219",
                    "r220",
                    "r221",
                    "r222",
                    "r223",
                    "r224",
                    "r226",
                    "r227",
                    "r228",
                    "r229",
                    "r230",
                    "r231",
                    "r233",
                    "r234",
                    "r236",
                    "r237",
                    "r239",
                    "r240",
                    "r241",
                    "r242",
                    "r243"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by plan name for share-based payment arrangement.",
                            "label":  "Plan Name [Axis]",
                            "terseLabel":  "Plan Name"
                            }
                        }
                    },
                "localname":  "PlanNameAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockBasedCompensationExpenseAndValuationInformationAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PlanNameDomain":  {
                "auth_ref":  [
                    "r213",
                    "r214",
                    "r215",
                    "r217",
                    "r218",
                    "r219",
                    "r220",
                    "r221",
                    "r222",
                    "r223",
                    "r224",
                    "r226",
                    "r227",
                    "r228",
                    "r229",
                    "r230",
                    "r231",
                    "r233",
                    "r234",
                    "r236",
                    "r237",
                    "r239",
                    "r240",
                    "r241",
                    "r242",
                    "r243"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Plan name for share-based payment arrangement.",
                            "label":  "Plan Name [Domain]",
                            "terseLabel":  "Plan Name"
                            }
                        }
                    },
                "localname":  "PlanNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockBasedCompensationExpenseAndValuationInformationAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_PreferredStockSharesAuthorized":  {
                "auth_ref":  [
                    "r12"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
                            "label":  "Preferred Stock Shares Authorized",
                            "terseLabel":  "Preferred stock, shares authorized"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityPreferredStockAdditionalInformationDetail"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockSharesOutstanding":  {
                "auth_ref":  [
                    "r12"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders.  Does not include preferred shares that have been repurchased.",
                            "label":  "Preferred Stock Shares Outstanding",
                            "terseLabel":  "Preferred stock, shares outstanding"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityPreferredStockAdditionalInformationDetail"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PrepaidExpenseAndOtherAssetsCurrent":  {
                "auth_ref":  [
                    "r20"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  10200.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
                            "label":  "Prepaid Expense And Other Assets Current",
                            "terseLabel":  "Prepaid expenses and other current assets"
                            }
                        }
                    },
                "localname":  "PrepaidExpenseAndOtherAssetsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent":  {
                "auth_ref":  [
                    "r9",
                    "r350",
                    "r361"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  10160.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer.",
                            "label":  "Prepaid Expense And Other Assets Noncurrent",
                            "terseLabel":  "Prepaid expenses and other assets, net"
                            }
                        }
                    },
                "localname":  "PrepaidExpenseAndOtherAssetsNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromIssuanceOfCommonStock":  {
                "auth_ref":  [
                    "r47"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  10040.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from the additional capital contribution to the entity.",
                            "label":  "Proceeds From Issuance Of Common Stock",
                            "terseLabel":  "Proceeds from issuance of common stock, net"
                            }
                        }
                    },
                "localname":  "ProceedsFromIssuanceOfCommonStock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi":  {
                "auth_ref":  [
                    "r49",
                    "r125"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  10090.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.",
                            "label":  "Proceeds From Sale Of Equity Securities Fv Ni",
                            "negatedLabel":  "Sales",
                            "terseLabel":  "Sales of equity securities",
                            "verboseLabel":  "Sale of equity securities"
                            }
                        }
                    },
                "localname":  "ProceedsFromSaleOfEquitySecuritiesFvNi",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfActivityForInvestmentsInEquitySecuritiesMeasuredAtFairValueDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProfitLoss":  {
                "auth_ref":  [
                    "r2",
                    "r29",
                    "r31",
                    "r36",
                    "r50",
                    "r63",
                    "r69",
                    "r77",
                    "r78",
                    "r108",
                    "r110",
                    "r113",
                    "r116",
                    "r118",
                    "r129",
                    "r148",
                    "r149",
                    "r150",
                    "r152",
                    "r153",
                    "r154",
                    "r155",
                    "r156",
                    "r157",
                    "r158",
                    "r272",
                    "r275",
                    "r276",
                    "r280",
                    "r281",
                    "r284",
                    "r287",
                    "r358"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows":  {
                        "order":  10100.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
                            "label":  "Profit Loss",
                            "terseLabel":  "Net loss"
                            }
                        }
                    },
                "localname":  "ProfitLoss",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows",
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentByTypeAxis":  {
                "auth_ref":  [
                    "r139"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
                            "label":  "Property Plant And Equipment By Type [Axis]",
                            "terseLabel":  "Long-Lived Tangible Asset"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentByTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentNet":  {
                "auth_ref":  [
                    "r139",
                    "r323",
                    "r359",
                    "r365"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  10130.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale.  Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
                            "label":  "Property Plant And Equipment Net",
                            "terseLabel":  "Fixed assets, net"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentNet",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentTypeDomain":  {
                "auth_ref":  [
                    "r138"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.  Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
                            "label":  "Property Plant And Equipment Type [Domain]",
                            "terseLabel":  "Long-Lived Tangible Asset"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RelatedPartyDomain":  {
                "auth_ref":  [
                    "r204",
                    "r314",
                    "r315"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families.  It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
                            "label":  "Related Party [Domain]",
                            "terseLabel":  "Related Party"
                            }
                        }
                    },
                "localname":  "RelatedPartyDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RelatedPartyTransactionLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Related Party Transaction [Line Items]",
                            "terseLabel":  "Related Party Transaction [Line Items]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Related Party Transactions [Abstract]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis":  {
                "auth_ref":  [
                    "r204",
                    "r314",
                    "r318",
                    "r338",
                    "r339",
                    "r340",
                    "r341",
                    "r342",
                    "r343",
                    "r344",
                    "r345",
                    "r346",
                    "r347",
                    "r348",
                    "r349"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of related party.  Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families.  It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
                            "label":  "Related Party Transactions By Related Party [Axis]",
                            "terseLabel":  "Related Party"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsByRelatedPartyAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r312",
                    "r313",
                    "r315",
                    "r319",
                    "r320"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for related party transactions.  Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
                            "label":  "Related Party Transactions Disclosure [Text Block]",
                            "terseLabel":  "Related Parties"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureRelatedParties"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis":  {
                "auth_ref":  [
                    "r258",
                    "r259"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by form of arrangement related to research and development.",
                            "label":  "Research And Development Arrangement Contract To Perform For Others By Type [Axis]",
                            "terseLabel":  "Research and Development Arrangement, Contract to Perform for Others, Type"
                            }
                        }
                    },
                "localname":  "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain":  {
                "auth_ref":  [
                    "r258",
                    "r259"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others.",
                            "label":  "Research And Development Arrangement Contract To Perform For Others Type [Domain]",
                            "terseLabel":  "Research and Development Arrangement, Contract to Perform for Others, Type"
                            }
                        }
                    },
                "localname":  "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ResearchAndDevelopmentExpense":  {
                "auth_ref":  [
                    "r257",
                    "r334",
                    "r396"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "order":  10100.0,
                        "parentTag":  "us-gaap_OperatingExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
                            "label":  "Research And Development Expense",
                            "terseLabel":  "Research and development expenses"
                            }
                        }
                    },
                "localname":  "ResearchAndDevelopmentExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ResearchAndDevelopmentExpenseMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Primary financial statement caption in which the reported facts about research and development expense have been included.",
                            "label":  "Research And Development Expense [Member]",
                            "terseLabel":  "Research and development"
                            }
                        }
                    },
                "localname":  "ResearchAndDevelopmentExpenseMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockBasedCompensationExpenseDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RestrictedCashNoncurrent":  {
                "auth_ref":  [
                    "r8",
                    "r59",
                    "r393"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  10140.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash restricted as to withdrawal or usage, classified as noncurrent.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
                            "label":  "Restricted Cash Noncurrent",
                            "periodEndLabel":  "Restricted cash",
                            "terseLabel":  "Restricted cash",
                            "verboseLabel":  "Restricted cash"
                            }
                        }
                    },
                "localname":  "RestrictedCashNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets",
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RestrictedStockUnitsRSUMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
                            "label":  "Restricted Stock Units R S U [Member]",
                            "terseLabel":  "Restricted stock units (RSUs) [Member]"
                            }
                        }
                    },
                "localname":  "RestrictedStockUnitsRSUMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockBasedCompensationExpenseAndValuationInformationAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanySRsusActivityAndPerformanceBasedRsusActivityDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityTables"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RetainedEarningsAccumulatedDeficit":  {
                "auth_ref":  [
                    "r15",
                    "r180",
                    "r323",
                    "r363",
                    "r376",
                    "r377"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  10050.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
                            "label":  "Retained Earnings Accumulated Deficit",
                            "terseLabel":  "Accumulated deficit"
                            }
                        }
                    },
                "localname":  "RetainedEarningsAccumulatedDeficit",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RetainedEarningsMember":  {
                "auth_ref":  [
                    "r0",
                    "r66",
                    "r67",
                    "r68",
                    "r70",
                    "r76",
                    "r78",
                    "r132",
                    "r248",
                    "r249",
                    "r250",
                    "r261",
                    "r262",
                    "r282",
                    "r373",
                    "r375"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
                            "label":  "Retained Earnings [Member]",
                            "terseLabel":  "Accumulated Deficit [Member]"
                            }
                        }
                    },
                "localname":  "RetainedEarningsMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax":  {
                "auth_ref":  [
                    "r103",
                    "r104",
                    "r109",
                    "r114",
                    "r115",
                    "r119",
                    "r120",
                    "r121",
                    "r192",
                    "r193",
                    "r335"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "order":  10080.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer.  Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
                            "label":  "Revenue From Contract With Customer Excluding Assessed Tax",
                            "terseLabel":  "Total Revenues",
                            "verboseLabel":  "Total Revenues"
                            }
                        }
                    },
                "localname":  "RevenueFromContractWithCustomerExcludingAssessedTax",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock":  {
                "auth_ref":  [
                    "r61",
                    "r184",
                    "r185",
                    "r186",
                    "r187",
                    "r188",
                    "r189",
                    "r190",
                    "r191",
                    "r195"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for revenue from contract with customer.",
                            "label":  "Revenue From Contract With Customer Policy [Text Block]",
                            "terseLabel":  "Revenue recognition"
                            }
                        }
                    },
                "localname":  "RevenueFromContractWithCustomerPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList":  {
                "auth_ref":  [
                    "r194"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.",
                            "label":  "Revenue From Contract With Customer Product And Service Extensible List",
                            "terseLabel":  "Revenue From Contract With Customer Product And Service [Extensible List]"
                            }
                        }
                    },
                "localname":  "RevenueFromContractWithCustomerProductAndServiceExtensibleList",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "xbrltype":  "enumerationSetItemType"
                },
            "us-gaap_RisksAndUncertaintiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Risks And Uncertainties [Abstract]"
                            }
                        }
                    },
                "localname":  "RisksAndUncertaintiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SaleOfStockNameOfTransactionDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
                            "label":  "Sale Of Stock Name Of Transaction [Domain]",
                            "terseLabel":  "Sale of Stock"
                            }
                        }
                    },
                "localname":  "SaleOfStockNameOfTransactionDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable":  {
                "auth_ref":  [
                    "r268"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
                            "label":  "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]",
                            "terseLabel":  "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable":  {
                "auth_ref":  [
                    "r244",
                    "r251"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about amount recognized for award under share-based payment arrangement.  Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
                            "label":  "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]",
                            "terseLabel":  "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockBasedCompensationExpenseDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock":  {
                "auth_ref":  [
                    "r244"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position.  Includes, but is not limited to, corresponding line item in financial statement.",
                            "label":  "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]",
                            "terseLabel":  "Schedule of Stock-based Compensation Expense"
                            }
                        }
                    },
                "localname":  "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable":  {
                "auth_ref":  [
                    "r316",
                    "r318"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule of quantitative and qualitative information pertaining to related party transactions.  Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
                            "label":  "Schedule Of Related Party Transactions By Related Party [Table]",
                            "terseLabel":  "Schedule Of Related Party Transactions By Related Party [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable":  {
                "auth_ref":  [
                    "r208",
                    "r210",
                    "r213",
                    "r214",
                    "r215",
                    "r217",
                    "r218",
                    "r219",
                    "r220",
                    "r221",
                    "r222",
                    "r223",
                    "r224",
                    "r226",
                    "r227",
                    "r228",
                    "r229",
                    "r230",
                    "r231",
                    "r233",
                    "r234",
                    "r236",
                    "r237",
                    "r239",
                    "r240",
                    "r241",
                    "r242",
                    "r243"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about share-based payment arrangement.",
                            "label":  "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]",
                            "terseLabel":  "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityFairValueOfESPPSharesDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock":  {
                "auth_ref":  [
                    "r216",
                    "r232",
                    "r235"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure for stock option plans.  Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
                            "label":  "Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]",
                            "terseLabel":  "Summary of Stock Option Activity"
                            }
                        }
                    },
                "localname":  "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock":  {
                "auth_ref":  [
                    "r238"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
                            "label":  "Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]",
                            "terseLabel":  "Fair Value of Employee Stock Options"
                            }
                        }
                    },
                "localname":  "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
                            "label":  "Schedule Of Sharebased Compensation Restricted Stock And Restricted Stock Units Activity Table [Text Block]",
                            "terseLabel":  "Summary of Company's RSUs Activity and Performance-Based RSUs Activity"
                            }
                        }
                    },
                "localname":  "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfStockByClassTable":  {
                "auth_ref":  [
                    "r11",
                    "r12",
                    "r13",
                    "r62",
                    "r92",
                    "r93",
                    "r163",
                    "r164",
                    "r165",
                    "r166",
                    "r167",
                    "r168",
                    "r169",
                    "r170",
                    "r171",
                    "r172",
                    "r173",
                    "r174",
                    "r175",
                    "r176",
                    "r177",
                    "r178",
                    "r179",
                    "r180"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule detailing information related to equity by class of stock.  Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer.  It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
                            "label":  "Schedule Of Stock By Class [Table]",
                            "terseLabel":  "Schedule Of Stock By Class [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfStockByClassTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockBasedCompensationExpenseAndValuationInformationAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanySRsusActivityAndPerformanceBasedRsusActivityDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityTables"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SellingGeneralAndAdministrativeExpense":  {
                "auth_ref":  [
                    "r41"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "order":  10110.0,
                        "parentTag":  "us-gaap_OperatingExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses.  Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products.  Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges.  General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
                            "label":  "Selling General And Administrative Expense",
                            "terseLabel":  "Selling, general and administrative expenses"
                            }
                        }
                    },
                "localname":  "SellingGeneralAndAdministrativeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost",
                            "terseLabel":  "Expense recorded"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription":  {
                "auth_ref":  [
                    "r211",
                    "r212"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of terms of share-based payment arrangement.  Includes, but is not limited to, type of award or grantee and reason for issuance.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Description",
                            "terseLabel":  "Description of plan"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate":  {
                "auth_ref":  [
                    "r247"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Discount rate from fair value on purchase date that participants pay for shares.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Purchase Date",
                            "terseLabel":  "Fair market value at discount"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    "r231"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value",
                            "terseLabel":  "Canceled / forfeited, Weighted Average Price"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanySRsusActivityAndPerformanceBasedRsusActivityDetail"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod":  {
                "auth_ref":  [
                    "r229"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period",
                            "verboseLabel":  "Granted, Number of Shares"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanySRsusActivityAndPerformanceBasedRsusActivityDetail"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    "r229"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value",
                            "terseLabel":  "Granted, Weighted Average Price"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanySRsusActivityAndPerformanceBasedRsusActivityDetail"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber":  {
                "auth_ref":  [
                    "r226",
                    "r227"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number",
                            "periodEndLabel":  "Ending balance, Unvested, Number of Shares",
                            "periodStartLabel":  "Beginning balance, Unvested, Number of Shares"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanySRsusActivityAndPerformanceBasedRsusActivityDetail"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    "r226",
                    "r227"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement.  Excludes share and unit options.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value",
                            "periodEndLabel":  "Ending balance, Unvested, Weighted Average Price",
                            "periodStartLabel":  "Beginning balance, Unvested, Weighted Average Price"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanySRsusActivityAndPerformanceBasedRsusActivityDetail"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod":  {
                "auth_ref":  [
                    "r230"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period",
                            "negatedLabel":  "Vested, Number of Shares"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanySRsusActivityAndPerformanceBasedRsusActivityDetail"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    "r230"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value",
                            "terseLabel":  "Vested, Weighted Average Price"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanySRsusActivityAndPerformanceBasedRsusActivityDetail"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate":  {
                "auth_ref":  [
                    "r241"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate",
                            "terseLabel":  "Dividend yield"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityFairValueOfESPPSharesDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityFairValueOfEmployeeStockOptionsDetail"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate":  {
                "auth_ref":  [
                    "r240"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The estimated measure of the percentage by which a share price is expected to fluctuate during a period.  Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean.  The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period.  That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate",
                            "terseLabel":  "Volatility"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityFairValueOfESPPSharesDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityFairValueOfEmployeeStockOptionsDetail"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate":  {
                "auth_ref":  [
                    "r242"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate",
                            "terseLabel":  "Risk-free interest rate"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityFairValueOfESPPSharesDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityFairValueOfEmployeeStockOptionsDetail"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]",
                            "terseLabel":  "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityFairValueOfESPPSharesDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate":  {
                "auth_ref":  [
                    "r247"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate",
                            "terseLabel":  "Employee subscription rate"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee":  {
                "auth_ref":  [
                    "r247"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The highest quantity of shares an employee can purchase under the plan per period.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee",
                            "terseLabel":  "Number of shares per employee"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations":  {
                "auth_ref":  [
                    "r225"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares under non-option equity instrument agreements that were either cancelled or expired.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations",
                            "negatedLabel":  "Canceled / forfeited, Number of Shares"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanySRsusActivityAndPerformanceBasedRsusActivityDetail"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized":  {
                "auth_ref":  [
                    "r215"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares authorized for issuance under share-based payment arrangement.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized",
                            "terseLabel":  "Common shares authorized to be issued"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant":  {
                "auth_ref":  [
                    "r247"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant",
                            "terseLabel":  "Shares available for purchase under ESPP"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber":  {
                "auth_ref":  [
                    "r219"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number",
                            "terseLabel":  "Vested and Exercisable, Options Outstanding"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetail"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r219"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price",
                            "terseLabel":  "Vested and Exercisable, Weighted-Average Exercise Price"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetail"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue":  {
                "auth_ref":  [
                    "r234"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value",
                            "terseLabel":  "Options Exercised, Aggregate Intrinsic Value"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod":  {
                "auth_ref":  [
                    "r220"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period",
                            "negatedLabel":  "Cancelled / forfeited, Options Outstanding"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetail"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r220"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average price of options that were either forfeited or expired.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price",
                            "terseLabel":  "Options cancelled / forfeited, Weighted-Average Exercise Price"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetail"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod":  {
                "auth_ref":  [
                    "r221"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Net number of share options (or share units) granted during the period.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period",
                            "terseLabel":  "Stock options granted"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross":  {
                "auth_ref":  [
                    "r221"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Gross number of share options (or share units) granted during the period.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross",
                            "verboseLabel":  "Granted, Options Outstanding"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetail"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    "r233"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value",
                            "terseLabel":  "Weighted average grant date fair value"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityFairValueOfESPPSharesDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityFairValueOfEmployeeStockOptionsDetail"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue":  {
                "auth_ref":  [
                    "r247"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value",
                            "periodEndLabel":  "Aggregate Intrinsic Value, Options Ending balance",
                            "periodStartLabel":  "Aggregate Intrinsic Value, Options Beginning balance"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":  {
                "auth_ref":  [
                    "r217",
                    "r218"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of options outstanding, including both vested and non-vested options.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number",
                            "periodEndLabel":  "Options Outstanding, Ending balance",
                            "periodStartLabel":  "Options Outstanding, Beginning balance"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetail"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r217",
                    "r218"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price",
                            "periodEndLabel":  "Weighted-Average Exercise Price, Options Ending balance",
                            "periodStartLabel":  "Weighted-Average Exercise Price, Options Beginning balance"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetail"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain":  {
                "auth_ref":  [
                    "r213",
                    "r214",
                    "r215",
                    "r217",
                    "r218",
                    "r219",
                    "r220",
                    "r221",
                    "r222",
                    "r223",
                    "r224",
                    "r226",
                    "r227",
                    "r228",
                    "r229",
                    "r230",
                    "r231",
                    "r233",
                    "r234",
                    "r236",
                    "r237",
                    "r239",
                    "r240",
                    "r241",
                    "r242",
                    "r243"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Award under share-based payment arrangement.",
                            "label":  "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]",
                            "terseLabel":  "Award Type"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockBasedCompensationExpenseAndValuationInformationAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanySRsusActivityAndPerformanceBasedRsusActivityDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityTables"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r222"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
                            "label":  "Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price",
                            "verboseLabel":  "Options exercised, Weighted-Average Exercise Price"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetail"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r221"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
                            "label":  "Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price",
                            "verboseLabel":  "Options granted, Weighted-Average Exercise Price"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetail"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1":  {
                "auth_ref":  [
                    "r239"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1",
                            "terseLabel":  "Expected life of options",
                            "verboseLabel":  "Expected term"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityFairValueOfESPPSharesDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityFairValueOfEmployeeStockOptionsDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockBasedCompensationExpenseAndValuationInformationAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1":  {
                "auth_ref":  [
                    "r247"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
                            "label":  "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1",
                            "terseLabel":  "Vested and Exercisable, Aggregate Intrinsic Value"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1":  {
                "auth_ref":  [
                    "r247"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1",
                            "terseLabel":  "Weighted-average remaining contractual term of stock options exercisable"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2":  {
                "auth_ref":  [
                    "r236"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2",
                            "terseLabel":  "Weighted-average remaining contractual term of stock options outstanding"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetail"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock":  {
                "auth_ref":  [
                    "r183",
                    "r256"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for shareholders' equity and share-based payment arrangement.  Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
                            "label":  "Shareholders Equity And Share Based Payments [Text Block]",
                            "terseLabel":  "Stockholders' Equity"
                            }
                        }
                    },
                "localname":  "ShareholdersEquityAndShareBasedPaymentsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquity"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SharesOutstanding":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares issued which are neither cancelled nor held in the treasury.",
                            "label":  "Shares Outstanding",
                            "periodEndLabel":  "Ending balance, Shares",
                            "periodStartLabel":  "Beginning balance, Shares"
                            }
                        }
                    },
                "localname":  "SharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShortTermInvestments":  {
                "auth_ref":  [
                    "r19",
                    "r353",
                    "r354",
                    "r360"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  10180.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
                            "label":  "Short Term Investments",
                            "terseLabel":  "Short-term investments",
                            "verboseLabel":  "Short-term investments"
                            }
                        }
                    },
                "localname":  "ShortTermInvestments",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShortTermLeaseCost":  {
                "auth_ref":  [
                    "r302",
                    "r309"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
                            "label":  "Short Term Lease Cost",
                            "terseLabel":  "Short term lease cost"
                            }
                        }
                    },
                "localname":  "ShortTermLeaseCost",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SignificantAccountingPoliciesTextBlock":  {
                "auth_ref":  [
                    "r60",
                    "r65"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for all significant accounting policies of the reporting entity.",
                            "label":  "Significant Accounting Policies [Text Block]",
                            "terseLabel":  "Summary of Significant Accounting Policies"
                            }
                        }
                    },
                "localname":  "SignificantAccountingPoliciesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_StatementEquityComponentsAxis":  {
                "auth_ref":  [
                    "r0",
                    "r27",
                    "r34",
                    "r35",
                    "r36",
                    "r66",
                    "r67",
                    "r68",
                    "r70",
                    "r76",
                    "r78",
                    "r91",
                    "r132",
                    "r173",
                    "r180",
                    "r248",
                    "r249",
                    "r250",
                    "r261",
                    "r262",
                    "r282",
                    "r289",
                    "r290",
                    "r291",
                    "r292",
                    "r293",
                    "r294",
                    "r311",
                    "r373",
                    "r374",
                    "r375"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by component of equity.",
                            "label":  "Statement Equity Components [Axis]",
                            "terseLabel":  "Equity Components"
                            }
                        }
                    },
                "localname":  "StatementEquityComponentsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Statement [Line Items]",
                            "terseLabel":  "Statement [Line Items]"
                            }
                        }
                    },
                "localname":  "StatementLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfCashFlowsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement Of Cash Flows [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfCashFlowsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfFinancialPositionAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement Of Financial Position [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfFinancialPositionAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfStockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement Of Stockholders Equity [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfStockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementTable":  {
                "auth_ref":  [
                    "r66",
                    "r67",
                    "r68",
                    "r91",
                    "r335"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
                            "label":  "Statement [Table]",
                            "terseLabel":  "Statement [Table]"
                            }
                        }
                    },
                "localname":  "StatementTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesNewIssues":  {
                "auth_ref":  [
                    "r12",
                    "r13",
                    "r173",
                    "r180"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of new stock issued during the period.",
                            "label":  "Stock Issued During Period Shares New Issues",
                            "terseLabel":  "Issuance of common stock from stock options exercises, net, Shares"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesNewIssues",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised":  {
                "auth_ref":  [
                    "r12",
                    "r13",
                    "r173",
                    "r180",
                    "r222"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of share options (or share units) exercised during the current period.",
                            "label":  "Stock Issued During Period Shares Stock Options Exercised",
                            "terseLabel":  "Exercised, Options Outstanding"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesStockOptionsExercised",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetail"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueNewIssues":  {
                "auth_ref":  [
                    "r12",
                    "r13",
                    "r173",
                    "r180"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Equity impact of the value of new stock issued during the period.  Includes shares issued in an initial public offering or a secondary public offering.",
                            "label":  "Stock Issued During Period Value New Issues",
                            "terseLabel":  "Value of shares sold under equity distribution agreement"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueNewIssues",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquity":  {
                "auth_ref":  [
                    "r13",
                    "r16",
                    "r17",
                    "r63",
                    "r123",
                    "r129",
                    "r287",
                    "r323"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  10020.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent.  The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest).  This excludes temporary equity and is sometimes called permanent equity.",
                            "label":  "Stockholders Equity",
                            "totalLabel":  "Total stockholders\u2019 equity"
                            }
                        }
                    },
                "localname":  "StockholdersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stockholders Equity [Abstract]",
                            "terseLabel":  "Stockholders\u2019 Equity"
                            }
                        }
                    },
                "localname":  "StockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest":  {
                "auth_ref":  [
                    "r0",
                    "r1",
                    "r35",
                    "r63",
                    "r66",
                    "r67",
                    "r68",
                    "r70",
                    "r76",
                    "r129",
                    "r132",
                    "r180",
                    "r248",
                    "r249",
                    "r250",
                    "r261",
                    "r262",
                    "r270",
                    "r271",
                    "r279",
                    "r282",
                    "r287",
                    "r289",
                    "r290",
                    "r294",
                    "r311",
                    "r374",
                    "r375"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests.  Amount excludes temporary equity.  Alternate caption for the concept is permanent equity.",
                            "label":  "Stockholders Equity Including Portion Attributable To Noncontrolling Interest",
                            "periodEndLabel":  "Ending balance",
                            "periodStartLabel":  "Beginning balance"
                            }
                        }
                    },
                "localname":  "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SubsidiarySaleOfStockAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of sale of the entity's stock.",
                            "label":  "Subsidiary Sale Of Stock [Axis]",
                            "terseLabel":  "Sale of Stock"
                            }
                        }
                    },
                "localname":  "SubsidiarySaleOfStockAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SupplementalCashFlowInformationAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Supplemental Cash Flow Information [Abstract]",
                            "terseLabel":  "Supplemental Disclosure of Cash Flow Information:"
                            }
                        }
                    },
                "localname":  "SupplementalCashFlowInformationAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_TreasuryStockCommonShares":  {
                "auth_ref":  [
                    "r181"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
                            "label":  "Treasury Stock Common Shares",
                            "terseLabel":  "Treasury stock, shares"
                            }
                        }
                    },
                "localname":  "TreasuryStockCommonShares",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_TreasuryStockCommonValue":  {
                "auth_ref":  [
                    "r28",
                    "r181",
                    "r182"
                    ],
                "calculation":  {
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "order":  10060.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.",
                            "label":  "Treasury Stock Common Value",
                            "negatedLabel":  "Treasury stock, 46 shares at cost"
                            }
                        }
                    },
                "localname":  "TreasuryStockCommonValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_TreasuryStockMember":  {
                "auth_ref":  [
                    "r26",
                    "r181"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Shares of an entity that have been repurchased by the entity.  This stock has no voting rights and receives no dividends.  Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital.  Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer.  Classified within temporary equity if redemption is outside the control of the issuer.",
                            "label":  "Treasury Stock [Member]",
                            "terseLabel":  "Treasury Stock [Member]"
                            }
                        }
                    },
                "localname":  "TreasuryStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_UseOfEstimates":  {
                "auth_ref":  [
                    "r95",
                    "r96",
                    "r97",
                    "r98",
                    "r99",
                    "r100",
                    "r101"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
                            "label":  "Use Of Estimates",
                            "terseLabel":  "Use of Estimates"
                            }
                        }
                    },
                "localname":  "UseOfEstimates",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_VariableLeaseCost":  {
                "auth_ref":  [
                    "r303",
                    "r309"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
                            "label":  "Variable Lease Cost",
                            "terseLabel":  "Variable lease expense"
                            }
                        }
                    },
                "localname":  "VariableLeaseCost",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding":  {
                "auth_ref":  [
                    "r80",
                    "r85"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
                            "label":  "Weighted Average Number Of Diluted Shares Outstanding",
                            "terseLabel":  "Weighted average shares used in computing net loss per common share diluted"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberOfDilutedSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic":  {
                "auth_ref":  [
                    "r79",
                    "r85"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
                            "label":  "Weighted Average Number Of Shares Outstanding Basic",
                            "terseLabel":  "Weighted average shares used in computing net loss per common share basic"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberOfSharesOutstandingBasic",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://www.organovo.com/20220930/taxonomy/role/StatementUnauditedCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "xbrltype":  "sharesItemType"
                }
            },
        "unitCount":  7
        }
    },
"std_ref":  {
    "r0":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "105",
        "URI":  "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
        },
    "r1":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "105",
        "URI":  "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
        },
    "r10":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(2))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r100":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
        },
    "r101":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
        },
    "r102":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/topic&trid=2134479"
        },
    "r103":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
        },
    "r104":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
        },
    "r105":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
        },
    "r106":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
        },
    "r107":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
        },
    "r108":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
        },
    "r109":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
        },
    "r11":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(27)(b))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r110":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
        },
    "r111":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
        },
    "r112":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
        },
    "r113":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "31",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
        },
    "r114":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
        },
    "r115":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
        },
    "r116":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
        },
    "r117":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
        },
    "r118":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
        },
    "r119":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "40",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
        },
    "r12":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(28))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r120":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "41",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
        },
    "r121":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "42",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
        },
    "r122":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
        },
    "r123":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 4.E)",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
        },
    "r124":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "320",
        "URI":  "https://asc.fasb.org/topic&trid=2196928"
        },
    "r125":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "321",
        "URI":  "https://asc.fasb.org/extlink&oid=123583714&loc=SL75117360-209713"
        },
    "r126":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "321",
        "URI":  "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714"
        },
    "r127":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "321",
        "URI":  "https://asc.fasb.org/topic&trid=75115024"
        },
    "r128":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(2)",
        "Topic":  "323",
        "URI":  "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
        },
    "r129":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "323",
        "URI":  "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
        },
    "r13":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(29))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r130":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "323",
        "URI":  "https://asc.fasb.org/topic&trid=2196965"
        },
    "r131":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "325",
        "URI":  "https://asc.fasb.org/topic&trid=2197064"
        },
    "r132":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
        },
    "r133":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "350",
        "URI":  "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
        },
    "r134":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "350",
        "URI":  "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
        },
    "r135":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "350",
        "URI":  "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r136":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)(1)",
        "Topic":  "350",
        "URI":  "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r137":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "350",
        "URI":  "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r138":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "360",
        "URI":  "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r139":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "360",
        "URI":  "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r14":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(1))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r140":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "360",
        "URI":  "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
        },
    "r141":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(c)",
        "Topic":  "410",
        "URI":  "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
        },
    "r142":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "420",
        "URI":  "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
        },
    "r143":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "440",
        "URI":  "https://asc.fasb.org/topic&trid=2144648"
        },
    "r144":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
        },
    "r145":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
        },
    "r146":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "20",
        "Subparagraph":  "(SAB Topic 5.Y.Q2)",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
        },
    "r147":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "20",
        "Subparagraph":  "(SAB Topic 5.Y.Q4)",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
        },
    "r148":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(i))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r149":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(ii))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r15":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(3))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r150":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iii)(A))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r151":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iii))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r152":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iv))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r153":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(5))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r154":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(i))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
        },
    "r155":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iii)(A))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
        },
    "r156":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iii)(B))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
        },
    "r157":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iv))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
        },
    "r158":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(5))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
        },
    "r159":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r16":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r160":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1D",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
        },
    "r161":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "69B",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
        },
    "r162":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "69C",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
        },
    "r163":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(CFRR 211.02)",
        "Topic":  "480",
        "URI":  "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
        },
    "r164":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
        },
    "r165":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644"
        },
    "r166":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r167":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r168":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r169":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r17":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(31))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r170":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r171":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
        },
    "r172":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
        },
    "r173":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
        },
    "r174":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
        },
    "r175":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644"
        },
    "r176":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644"
        },
    "r177":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
        },
    "r178":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
        },
    "r179":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
        },
    "r18":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(32))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r180":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.3-04)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
        },
    "r181":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
        },
    "r182":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
        },
    "r183":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/topic&trid=2208762"
        },
    "r184":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045"
        },
    "r185":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
        },
    "r186":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
        },
    "r187":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045"
        },
    "r188":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
        },
    "r189":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
        },
    "r19":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(8))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r190":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
        },
    "r191":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
        },
    "r192":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
        },
    "r193":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
        },
    "r194":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
        },
    "r195":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/topic&trid=49130388"
        },
    "r196":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(i)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r197":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(ii)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r198":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(01)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r199":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(02)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r2":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "205",
        "URI":  "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
        },
    "r20":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(9))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r200":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(02)(A)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r201":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(02)(B)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r202":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(02)(C)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r203":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(03)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r204":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(n)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r205":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
        },
    "r206":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "80",
        "Subparagraph":  "(d)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
        },
    "r207":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "80",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
        },
    "r208":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1D",
        "Publisher":  "FASB",
        "Section":  "35",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
        },
    "r209":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "35",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
        },
    "r21":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19(a))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r210":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "35",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
        },
    "r211":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901"
        },
    "r212":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r213":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r214":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r215":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(3)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r216":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r217":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r218":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(ii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r219":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r22":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19-26)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r220":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r221":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(01)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r222":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(02)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r223":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(03)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r224":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(04)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r225":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(3)-(4)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r226":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r227":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(ii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r228":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r229":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(01)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r23":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.20)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r230":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(02)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r231":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(03)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r232":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r233":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r234":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r235":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r236":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r237":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r238":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r239":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r24":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.21)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r240":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(ii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r241":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(iii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r242":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(iv)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r243":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(v)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r244":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r245":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)(1)(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r246":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r247":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r248":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
        },
    "r249":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
        },
    "r25":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r250":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
        },
    "r251":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 14.F)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
        },
    "r252":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
        },
    "r253":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
        },
    "r254":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Subparagraph":  "(a)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929"
        },
    "r255":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929"
        },
    "r256":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/topic&trid=2228938"
        },
    "r257":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "730",
        "URI":  "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
        },
    "r258":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "730",
        "URI":  "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380"
        },
    "r259":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "730",
        "URI":  "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380"
        },
    "r26":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29,30)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r260":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
        },
    "r261":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(2)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
        },
    "r262":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(3)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
        },
    "r263":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB TOPIC 6.I.7)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r264":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
        },
    "r265":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "31",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "805",
        "URI":  "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
        },
    "r266":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "808",
        "URI":  "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
        },
    "r267":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "808",
        "URI":  "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
        },
    "r268":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "808",
        "URI":  "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
        },
    "r269":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "808",
        "URI":  "https://asc.fasb.org/topic&trid=5833765"
        },
    "r27":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29-31)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r270":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
        },
    "r271":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
        },
    "r272":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
        },
    "r273":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
        },
    "r274":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
        },
    "r275":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(1)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
        },
    "r276":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
        },
    "r277":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bb)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
        },
    "r278":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
        },
    "r279":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4I",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
        },
    "r28":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.30)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r280":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4J",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
        },
    "r281":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4K",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
        },
    "r282":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)(3)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
        },
    "r283":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)(4)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
        },
    "r284":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
        },
    "r285":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "820",
        "URI":  "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
        },
    "r286":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
        },
    "r287":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
        },
    "r288":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "230",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
        },
    "r289":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
        },
    "r29":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
        },
    "r290":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r291":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r292":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(c)",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r293":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r294":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
        },
    "r295":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
        },
    "r296":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
        },
    "r297":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
        },
    "r298":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
        },
    "r299":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)(3)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
        },
    "r3":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
        },
    "r30":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
        },
    "r300":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(3)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
        },
    "r301":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
        },
    "r302":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
        },
    "r303":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
        },
    "r304":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(g)(1)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
        },
    "r305":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(g)(3)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
        },
    "r306":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(g)(4)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
        },
    "r307":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
        },
    "r308":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
        },
    "r309":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "53",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
        },
    "r31":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
        },
    "r310":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/subtopic&trid=77888251"
        },
    "r311":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(3)(iii)(03)",
        "Topic":  "848",
        "URI":  "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
        },
    "r312":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r313":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r314":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r315":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r316":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r317":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
        },
    "r318":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
        },
    "r319":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
        },
    "r32":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
        },
    "r320":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/topic&trid=2122745"
        },
    "r321":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "852",
        "URI":  "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
        },
    "r322":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "852",
        "URI":  "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
        },
    "r323":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "852",
        "URI":  "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
        },
    "r324":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)(1)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r325":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)(2)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r326":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(bb)(3)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r327":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(1)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r328":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(2)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r329":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(3)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r33":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
        },
    "r330":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(1)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r331":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(2)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r332":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(3)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r333":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "910",
        "URI":  "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
        },
    "r334":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "730",
        "Topic":  "912",
        "URI":  "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
        },
    "r335":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 11.L)",
        "Topic":  "924",
        "URI":  "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
        },
    "r336":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "926",
        "URI":  "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
        },
    "r337":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "340",
        "Topic":  "928",
        "URI":  "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
        },
    "r338":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
        },
    "r339":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
        },
    "r34":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
        },
    "r340":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
        },
    "r341":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
        },
    "r342":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
        },
    "r343":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
        },
    "r344":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "33",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
        },
    "r345":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "33",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
        },
    "r346":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "35A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
        },
    "r347":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "35A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
        },
    "r348":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(c)(1)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
        },
    "r349":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(c)(2)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
        },
    "r35":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
        },
    "r350":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(10))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r351":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(11))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r352":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(23))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r353":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(4))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r354":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(5))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r355":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(22))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r356":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(26))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r357":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(27))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r358":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "235",
        "Subparagraph":  "(SX 210.9-05(b)(2))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
        },
    "r359":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "360",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
        },
    "r36":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
        },
    "r360":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(1)(g))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r361":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(10))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r362":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(12))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r363":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(23)(a)(4))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r364":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(25))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r365":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(8))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r366":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(18))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r367":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(22))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r368":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(23))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r369":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(3)(b))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r37":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(20))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r370":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(9))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r371":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Subparagraph":  "(d)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
        },
    "r372":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "29F",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
        },
    "r373":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r374":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)(1)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r375":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)(2)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r376":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(2)(i)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r377":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(h)(2)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r378":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-12B(Column B)(Footnote 1))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
        },
    "r379":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-12B(Column B)(Footnote 6))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
        },
    "r38":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(24))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r380":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-12B(Column B)(Footnote 7))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
        },
    "r381":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-12B(Column C)(Footnote 1))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
        },
    "r382":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-12B(Column C)(Footnote 6))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
        },
    "r383":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-12B(Column C)(Footnote 7))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
        },
    "r384":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-12B(Column D)(Footnote 1))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
        },
    "r385":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-12B(Column D)(Footnote 6))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
        },
    "r386":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-12B(Column D)(Footnote 7))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
        },
    "r387":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5D",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-13D(Column B)(Footnote 2))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
        },
    "r388":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5D",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-13D(Column C)(Footnote 2))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
        },
    "r389":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-15(Column A))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
        },
    "r39":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(25))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r390":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-15(Column B))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
        },
    "r391":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-15(Column C))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
        },
    "r392":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-15(Column D))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
        },
    "r393":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "210",
        "Topic":  "954",
        "URI":  "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
        },
    "r394":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "310",
        "Subparagraph":  "(c)",
        "Topic":  "976",
        "URI":  "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
        },
    "r395":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "310",
        "Subparagraph":  "(b)",
        "Topic":  "978",
        "URI":  "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
        },
    "r396":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "985",
        "URI":  "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
        },
    "r397":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b"
        },
    "r398":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b-2"
        },
    "r399":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "d1-1"
        },
    "r4":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
        },
    "r40":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(4))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r400":  {
        "Name":  "Form 10-Q",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "308",
        "Subsection":  "a"
        },
    "r401":  {
        "Name":  "Forms 10-K, 10-Q, 20-F",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "13",
        "Subsection":  "a-1"
        },
    "r402":  {
        "Name":  "Regulation S-T",
        "Number":  "232",
        "Publisher":  "SEC",
        "Section":  "405"
        },
    "r41":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.4)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r42":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.7(b))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r43":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.7)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r44":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.9)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r45":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
        },
    "r46":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
        },
    "r47":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
        },
    "r48":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
        },
    "r49":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3444-108585"
        },
    "r5":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
        },
    "r50":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
        },
    "r51":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
        },
    "r52":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
        },
    "r53":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
        },
    "r54":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
        },
    "r55":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
        },
    "r56":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
        },
    "r57":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
        },
    "r58":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
        },
    "r59":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
        },
    "r6":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
        },
    "r60":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
        },
    "r61":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
        },
    "r62":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(d))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r63":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(g)(1)(ii))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r64":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(h))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r65":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/topic&trid=2122369"
        },
    "r66":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "23",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
        },
    "r67":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
        },
    "r68":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
        },
    "r69":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(2)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
        },
    "r7":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(1))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r70":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(3)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
        },
    "r71":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
        },
    "r72":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
        },
    "r73":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
        },
    "r74":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
        },
    "r75":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
        },
    "r76":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
        },
    "r77":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
        },
    "r78":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
        },
    "r79":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
        },
    "r8":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(17))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r80":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
        },
    "r81":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
        },
    "r82":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "60B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
        },
    "r83":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "60B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
        },
    "r84":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
        },
    "r85":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
        },
    "r86":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
        },
    "r87":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
        },
    "r88":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
        },
    "r89":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
        },
    "r9":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(18))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r90":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "52",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
        },
    "r91":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
        },
    "r92":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
        },
    "r93":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
        },
    "r94":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r95":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r96":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r97":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
        },
    "r98":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
        },
    "r99":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
        }
    },
"version":  "2.1"
}


4 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/17/20  Organovo Holdings, Inc.           8-K:3,5,8,9 8/17/20    3:67K                                    ActiveDisclosure/FA
10/11/19  Organovo Holdings, Inc.           8-K:5,9    10/10/19    2:35K                                    ActiveDisclosure/FA
 7/27/18  Organovo Holdings, Inc.           8-K:5,9     7/26/18    3:185K                                   ActiveDisclosure/FA
 2/03/12  Organovo Holdings, Inc.           8-K:3,5,8,9 1/30/12    7:686K                                   EdgarAgents LLC/FA
Top
Filing Submission 0001564590-22-037381   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 3, 10:42:07.5am ET